Mental and behavioural disorders due to tobacco

F5_TOBAC

nicotine dependence: Physical and psychological dependence on nicotine.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — F17 Hospital discharge: ICD-9 — 3051 Cause of death: ICD-10 — F17 Cause of death: ICD-9 — 3051 2 out of 7 registries used, show all original rules.	3304
4. Check minimum number of events None	3304
5. Include endpoints None	3304
6. Filter based on genotype QC (FinnGen only)	3304

Control definitions (FinnGen only)

Control exclude: F5_SUBSNOALCO

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: F10-F19
Name in latin: Perturbationes mentis et modi se gerendi ex usu tabaci

NAME	F5_TOBAC
CONTROL_EXCLUDE	F5_SUBSNOALCO
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	F17
HD_ICD_9	3051
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	F17
COD_ICD_9	3051
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Mental and behavioural disorders due to tobacco based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Smoking dependency

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3304	1718	1586
Unadjusted period prevalence (%)	0.64	0.59	0.70
Median age at first event (years)	56.10	53.46	58.95

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2848: Matched controls
28480

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

F17.20

ICD-10 Finland

Addiction relationship caused by tobacco addiction relationship currently independent

2279.3

323.0

805

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

11.7

323.0

927

1128

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

1091.8

323.0

2006

N07BA03

ATC

varenicline; oral

11.5

318.0

637

695

R03BB04

ATC

tiotropium bromide; inhalant

7.3

274.2

740

1306

F17.22

ICD-10 Finland

Addiction-related addiction currently uses controlled substitution treatment

599.1

226.8

222

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

11.6

215.8

422

419

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.2

187.5

1612

8208

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

9.3

159.9

351

423

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

6.2

156.5

460

857

Z72.0

ICD-10 Finland

Tobacco use

11.2

140.6

277

271

J18.9

ICD-10 Finland

Pneumonia, unspecified

3.3

140.4

884

3407

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

12.1

139.7

265

240

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

6.1

127.4

375

690

R03AC02

ATC

salbutamol; inhalant

2.6

126.1

1770

11040

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

4.4

123.8

500

1308

K05.31

ICD-10 Finland

Periodontitis pronounced

4.2

122.8

528

1465

F17.1

ICD-10 Finland

Mental and behavioural disorders due to use of tobacco, harmful use

252.5

118.8

121

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

3.1

118.5

799

3170

N05AH04

ATC

quetiapine; oral

3.3

116.3

689

2485

F17.3

ICD-10 Finland

Mental and behavioural disorders due to use of tobacco, withdrawal state

392.7

114.3

114

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

8.6

111.3

254

321

T36

ICD-10 Finland

Poisoning by systemic antibiotics

6.9

110.2

293

467

XG410

NOMESCO Finland

Flow-volume spirometry

6.7

109.0

294

478

J45.9

ICD-10 Finland

Asthma, unspecified

3.1

108.8

721

2803

N06AX11

ATC

mirtazapine; oral

2.6

107.5

1119

5741

N05BA04

ATC

oxazepam; oral

2.8

106.2

892

4033

H02AB06

ATC

prednisolone; systemic

2.4

106.2

1552

9498

F32.9

ICD-10 Finland

Depressive episode, unspecified

3.6

103.1

536

1731

N07BB01

ATC

disulfiram; oral

6.0

97.4

285

514

UGC12

NOMESCO Finland

Flexible bronchoscopy

4.3

93.8

379

975

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

3.3

92.5

534

1854

N05CD07

ATC

temazepam; oral

3.6

90.3

463

1465

P17

ICPC

Tobacco abuse

14.6

89.9

155

112

N06AB04

ATC

citalopram; systemic

2.6

89.8

796

3650

N05CF01

ATC

zopiclone; oral

2.4

89.5

1043

5541

N05AA02

ATC

levomepromazine; systemic

6.1

88.7

258

460

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.8

87.7

680

2871

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

8.1

87.5

206

272

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

4.2

87.2

363

957

R95

ICPC

Chron obstructive pulmonary disease

8.6

86.8

196

242

R03AK06

ATC

salmeterol and fluticasone; inhalant

3.0

85.8

569

2169

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

4.2

85.5

360

958

R06.0

ICD-10 Finland

Dyspnoea

2.5

84.8

831

4007

N02AX02

ATC

tramadol; systemic, rectal

2.2

84.0

1377

8532

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

8.7

82.4

185

226

N06AX16

ATC

venlafaxine; oral

2.9

81.1

566

2225

N05BA01

ATC

diazepam; systemic, rectal

3.0

79.1

514

1923

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

4.3

78.8

320

821

N05AH03

ATC

olanzapine; systemic

4.7

78.8

290

675

AA1AD

NOMESCO Finland

CT of head and brain

2.5

78.2

758

3605

C03CA01

ATC

furosemide; systemic

2.4

74.9

767

3744

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

8.4

73.0

167

210

SPAT1254

SPAT

Administration of medicine

2.9

72.4

519

2060

EBA00

NOMESCO Finland

Extraction of tooth

2.1

71.9

1096

6435

J01FF01

ATC

clindamycin; systemic

2.2

70.7

926

5072

J20

ICD-10 Finland

Acute bronchitis

3.3

70.6

391

1298

SPAT1263

SPAT

Sampling

2.0

69.8

1305

8318

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

9.6

68.9

145

158

A02BC02

ATC

pantoprazole; systemic

2.0

67.6

1897

14124

N05AX08

ATC

risperidone; systemic

4.0

65.0

285

779

N02BE01

ATC

paracetamol; systemic, rectal

2.5

65.0

2484

20925

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.1

64.9

1088

6572

F10.20

ICD-10 Finland

Alcohol dependence currently independent

8.1

64.6

150

193

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

3.6

64.4

322

984

N03AX16

ATC

pregabalin; oral

2.2

64.2

781

4098

M54.5

ICD-10 Finland

Low back pain

2.1

63.9

1047

6254

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

9.0

63.8

139

161

SPAT1240

SPAT

Therapeutic discussion

3.0

63.7

415

1538

J01MA12

ATC

levofloxacin; systemic

2.4

62.6

640

3079

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

2.0

61.0

1269

8285

SPAT1310

SPAT

Counselling related to known health issue

2.1

60.8

988

5853

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.6

60.5

520

2275

N06AX12

ATC

bupropion; oral

3.8

59.9

270

755

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.1

58.7

857

4843

R02

ICPC

Shortness of breath/dyspnoea

2.8

58.3

415

1621

N03AX09

ATC

lamotrigine; oral

4.3

58.1

228

561

WZC30

NOMESCO Finland

Teaching

2.6

57.7

498

2179

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

3.6

57.6

286

866

N06AB03

ATC

fluoxetine; oral

2.7

57.4

450

1864

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.1

56.9

860

4916

P15

ICPC

Chronic alcohol abuse

5.5

55.5

171

325

N03AG01

ATC

valproic acid; systemic, rectal

3.8

55.4

249

693

F17.2

ICD-10 Finland

Mental and behavioural disorders due to use of tobacco, dependence syndrome

15.0

55.1

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.8

54.0

1525

10932

EBA15

NOMESCO Finland

Extraction of large number of teeth

4.6

53.3

194

443

J45.1

ICD-10 Finland

Nonallergic asthma

3.4

53.2

285

914

J01DB01

ATC

cefalexin; oral

2.1

52.8

2372

19997

E66.01

ICD-10 Finland

Obesity due to excess calories

3.0

52.3

324

1153

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

4.6

52.2

192

443

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

3.1

52.1

320

1130

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

517.0

51.6

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

8.3

51.2

117

147

K04.5

ICD-10 Finland

Chronic apical periodontitis

2.0

51.0

816

4731

XG466

NOMESCO Finland

Sleep oxymetry

4.8

50.2

176

386

N06AB10

ATC

escitalopram; oral

2.2

50.2

645

3408

P01AB01

ATC

metronidazole; oral, rectal

1.9

49.7

1156

7672

G47.3

ICD-10 Finland

Sleep apnoea

2.1

49.5

725

4048

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.0

49.4

843

5000

XFP96

NOMESCO Finland

Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation

7.8

49.3

117

156

N05AX12

ATC

aripiprazole; systemic

4.8

49.3

171

371

N02AA05

ATC

oxycodone; systemic

2.5

48.8

447

2002

N03AE01

ATC

clonazepam; systemic

3.7

48.5

227

653

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.7

47.8

352

1393

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

2.7

47.8

363

1466

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

8.2

47.5

109

138

L03

ICPC

Low back symptom/complaint

2.0

47.4

734

4178

F29

ICD-10 Finland

Unspecified nonorganic psychosis

5.0

47.4

160

337

R03AL08

ATC

vilanterol, umeclidinium bromide and fluticasone furoate; inhalant

9.1

47.4

102

116

N05AF03

ATC

chlorprothixene; systemic

5.6

47.4

144

269

N06AX21

ATC

duloxetine; oral

2.6

47.3

384

1610

R03AK07

ATC

formoterol and budesonide; inhalant

2.1

47.3

631

3380

J43.9

ICD-10 Finland

Emphysema, unspecified

9.1

46.6

100

113

WX110

NOMESCO Finland

Local anesthesy

1.8

46.6

1987

15928

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.5

46.5

416

1839

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

3.0

46.5

292

1045

N05BA12

ATC

alprazolam; oral

2.7

46.4

354

1430

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

3.6

46.4

222

650

SPAT1215

SPAT

Assessment of need for medical rehabilitation

3.9

46.3

200

537

J01MA14

ATC

moxifloxacin; systemic

2.8

46.0

325

1255

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.9

45.9

882

5437

F10.24

ICD-10 Finland

Alcohol depence active use

8.4

45.8

103

126

C07AB07

ATC

bisoprolol; oral

1.8

45.2

1240

8607

S18

ICPC

Laceration/cut

1.8

45.1

1172

7995

F10.09

ICD-10 Finland

Alcohol intoxication UNS

6.1

45.1

127

216

F10.25

ICD-10 Finland

Alcohol dependence continuous use

7.1

45.0

113

164

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

5.5

44.9

137

257

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.4

44.2

426

1951

R06.2

ICD-10 Finland

Wheezing

4.0

44.0

187

494

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

5.4

43.9

138

268

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

4.1

43.8

179

457

B18.2

ICD-10 Finland

Chronic viral hepatitis C

16.1

43.5

N06AB06

ATC

sertraline; oral

2.5

43.2

368

1580

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.4

43.2

413

1886

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

15.8

43.2

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.8

43.2

983

6393

M79.6

ICD-10 Finland

Pain in limb

1.8

43.0

1012

6655

N05BA06

ATC

lorazepam; systemic, sublingual

3.8

42.6

192

534

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

8.6

42.5

112

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

3.2

42.5

239

790

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

12.1

42.3

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

9.7

42.1

L28

ICPC

Limited function/disability (L)

2.3

42.1

427

2003

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

69.6

42.1

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

3.5

42.0

206

615

J01AA02

ATC

doxycycline; systemic

1.8

41.6

2200

18487

J46

ICD-10 Finland

Status asthmaticus

5.1

41.4

135

274

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.7

41.2

1349

9789

B01AC04

ATC

clopidogrel; oral

2.3

41.1

448

2176

J37.0

ICD-10 Finland

Chronic laryngitis

4.8

41.1

142

307

R03AK03

ATC

[D] fenoterol & other drugs for obstructive airway dis; inhalant

3.8

41.0

186

520

P29

ICPC

Psychological sympt/compl other

3.3

40.4

221

717

N05BE01

ATC

buspirone; oral

5.1

40.3

132

269

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.1

40.1

526

2772

GD1AD

NOMESCO Finland

Thorax CT examination

3.8

40.0

180

500

SPAT1301

SPAT

No procedures

1.8

39.9

873

5571

F32

ICD-10 Finland

Depressive episode

3.4

39.6

208

654

F61.0

ICD-10 Finland

Mixed personality disorders

7.2

39.5

140

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

4.6

39.4

143

325

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

87.3

38.9

H02AB04

ATC

methylprednisolone; systemic

2.2

38.8

452

2259

J96.1

ICD-10 Finland

Chronic respiratory failure

6.3

38.4

105

172

N05BA02

ATC

chlordiazepoxide; systemic

5.0

38.4

127

262

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.7

38.3

293

1180

R74

ICPC

Upper respiratory infection acute

1.8

38.2

829

5260

N03AX12

ATC

gabapentin; oral

2.1

38.0

480

2484

SPAT1283

SPAT

Restricted health certificate

2.0

37.6

544

2978

J45

ICD-10 Finland

Asthma

2.5

37.6

316

1342

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.6

37.5

298

1226

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

10.2

37.5

R03DA04

ATC

theophylline; systemic, rectal

3.6

37.4

176

507

Z86.4

ICD-10 Finland

Personal history of psychoactive substance abuse

55.8

37.4

A06AD11

ATC

lactulose; oral

2.3

37.4

373

1732

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.8

37.4

742

4564

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.8

37.3

264

1016

S10

ICPC

Boil/carbuncle

3.2

37.3

213

712

N06AB05

ATC

paroxetine; oral

3.0

37.0

233

832

R60.0

ICD-10 Finland

Localized oedema

2.4

36.8

334

1477

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.1

36.8

471

2449

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

11.4

36.5

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.9

36.0

608

3521

M54.4

ICD-10 Finland

Lumbago with sciatica

2.0

35.8

510

2769

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.9

35.8

603

3489

K02.1

ICD-10 Finland

Caries of dentine

1.6

35.6

1621

12683

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

3.2

35.6

203

677

FP1B5

NOMESCO Finland

Resting ECG, 12 leads

7.7

35.5

112

F15.2

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome

+∞

35.5

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

3.3

35.4

190

607

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

351.4

35.0

F13.20

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent

351.4

35.0

SPAT1234

SPAT

Support of social functional capacity

3.6

34.9

165

477

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

2.2

34.7

387

1890

N05AB03

ATC

perphenazine; systemic, rectal

3.9

34.6

149

398

F11.20

ICD-10 Finland

Addiction-induced dependence caused by opiates currently independent

+∞

34.4

F20.9

ICD-10 Finland

Schizophrenia, unspecified

5.2

34.3

109

215

N02AJ06

ATC

codeine and paracetamol; systemic

1.7

34.3

1074

7562

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.7

34.2

842

5519

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.8

34.0

806

5222

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

6.9

34.0

127

V03AA01

ATC

5.9

33.9

169

J01DA01

ATC

[U] cefalexin; systemic

1.6

33.8

1732

13896

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

4.0

33.6

140

364

L17

ICPC

Foot/toe symptom/complaint

1.8

33.5

681

4194

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

+∞

33.4

S06.0

ICD-10 Finland

Concussion

2.4

33.4

304

1344

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.1

33.3

398

2003

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.3

33.1

323

1480

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.6

32.9

1363

10312

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

8.9

32.9

WX290

NOMESCO Finland

Other blockade of nerve

1.6

32.8

1268

9416

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

172.0

32.8

WX722

NOMESCO Finland

PEEP

3.2

32.7

184

606

SPAT1149

SPAT

Suture or treatment of traumatic wound

2.2

32.5

381

1900

N05AD01

ATC

haloperidol; systemic

4.3

32.4

124

298

M79.1

ICD-10 Finland

Myalgia

2.1

32.1

393

1997

H02AB07

ATC

prednisone; oral

2.1

32.1

417

2171

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.9

31.9

598

3575

WX892

NOMESCO Finland

Monitored bed care

2.6

31.7

245

990

SPAT1260

SPAT

Consultation of another employee

1.9

31.7

504

2839

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

15.5

31.7

SPAT1216

SPAT

Assessment of functional ability

2.1

31.6

394

2014

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.3

31.6

330

1559

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.6

31.5

1176

8624

I50.9

ICD-10 Finland

Heart failure, unspecified

2.4

31.2

296

1334

SPAT1227

SPAT

Substance abuse rehabilitation

12.1

31.2

R96

ICPC

Asthma

2.4

31.1

276

1202

N05AB01

ATC

dixyrazine; systemic

7.0

31.1

114

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

6.2

31.1

140

XF400

NOMESCO Finland

ECG with 12 standard connections

2.0

30.9

446

2422

WX408

NOMESCO Finland

General anesthesy, balanced

1.7

30.8

774

5073

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.4

30.8

286

1276

N06AA09

ATC

amitriptyline; systemic

2.3

30.8

298

1356

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.2

30.8

332

1592

A07AA02

ATC

nystatin; oral

2.9

30.6

196

706

R05

ICPC

Cough

1.8

30.6

613

3739

M25.5

ICD-10 Finland

Pain in joint

1.7

30.5

792

5240

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

8.7

30.4

R03AL03

ATC

vilanterol and umeclidinium bromide; inhalant

7.9

30.4

F11.24

ICD-10 Finland

Addiction-induced dependence caused by opiates active addiction

+∞

30.3

SPAT1265

SPAT

Breathalyser

8.4

30.2

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.6

30.2

241

991

N05AH02

ATC

clozapine; systemic

5.3

30.0

183

I10

ICD-10 Finland

Essential (primary) hypertension

1.6

29.7

1429

11110

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

7.0

29.6

108

T90

ICPC

Diabetes non-insulin dependent

1.8

29.5

618

3821

F34.1

ICD-10 Finland

Dysthymia

3.7

29.3

133

372

Z72.1

ICD-10 Finland

Alcohol use

6.6

29.2

117

N06AX05

ATC

trazodone; oral

4.5

29.1

105

238

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

5.3

29.1

177

R03BA05

ATC

fluticasone; inhalant

1.9

29.1

511

2977

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

2.8

29.0

192

708

SPAT1249

SPAT

Treatment-related counselling outside office

1.6

28.9

1075

7819

348

Kela drug reimbursment

Roflumilast

25.3

28.8

XQ800

NOMESCO Finland

Prick test

2.5

28.8

250

1076

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

5.2

28.7

180

T74.1

ICD-10 Finland

Physical abuse

5.6

28.5

156

J45.8

ICD-10 Finland

Mixed asthma

4.0

28.5

117

300

SPAT1312

SPAT

General health counselling

1.6

28.4

858

5899

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

4.4

28.3

106

250

P76

ICPC

Depressive disorder

2.7

28.1

203

788

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

3.5

28.1

139

417

R51.80

ICD-10 Finland

Headache

2.0

28.0

412

2245

F11.25

ICD-10 Finland

Relationship caused by opiates continuously used

146.4

27.7

A10BA02

ATC

metformin; oral

1.7

27.6

716

4709

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

2.4

27.6

249

1094

K08.3

ICD-10 Finland

Retained dental root

2.5

27.5

234

995

N06AX03

ATC

mianserin; oral

3.0

27.5

164

564

Z01.8

ICD-10 Finland

Other specified special examinations

1.8

27.5

585

3626

N04AA02

ATC

biperiden; systemic

4.9

27.5

189

R03AC03

ATC

terbutaline; inhalant

2.0

27.3

394

2132

F19.21

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances currently independent but staying in a controlling environment

+∞

27.1

E66.9

ICD-10 Finland

Obesity, unspecified

3.6

27.1

128

371

R07.4

ICD-10 Finland

Chest pain, unspecified

1.7

26.9

697

4579

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.9

26.9

442

2508

UJF30

NOMESCO Finland

Ileoscopy through colon

2.3

26.8

277

1299

L02

ICPC

Back symptom/complaint

2.3

26.7

271

1261

JN3AD

NOMESCO Finland

Abdominal CT examination

2.4

26.6

242

1065

Z72.2

ICD-10 Finland

Drug use

25.0

26.6

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.5

26.4

221

933

P16

ICPC

Acute alcohol abuse

5.2

26.2

160

X58

ICD-10 Finland

Exposure to other specified factors

1.9

26.2

402

2225

R5140

NOMESCO Finland

Monitoring the use of the aid

2.1

26.1

325

1654

SPAT1235

SPAT

Mental health, emotional support

9.0

26.0

P19

ICPC

Drug abuse

16.6

25.8

F17.9

ICD-10 Finland

Mental and behavioural disorders due to use of tobacco, unspecified mental and behavioural disorder

262.9

25.7

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

5.1

25.6

164

SPAT1153

SPAT

Removal of sutures

1.6

25.5

823

5727

L40.3

ICD-10 Finland

Pustulosis palmaris et plantaris

5.6

25.5

136

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.3

25.5

258

1197

J01CA04

ATC

amoxicillin; systemic

1.6

25.4

2196

19276

R53

ICD-10 Finland

Malaise and fatigue

1.8

25.4

511

3102

SPAT1229

SPAT

Assessment of need for aid

2.4

25.3

220

945

ZYC01

SPAT

2.6

25.3

189

749

K04.7

ICD-10 Finland

Periapical abscess without sinus

2.6

25.2

198

805

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.6

25.2

192

769

XG474

NOMESCO Finland

Exhalation nntrogen oxide

3.6

25.2

118

340

G44.2

ICD-10 Finland

Tension-type headache

2.0

25.2

364

1965

F41.1

ICD-10 Finland

Generalized anxiety disorder

3.0

25.1

149

510

N05AN01

ATC

lithium; oral

4.0

25.1

103

265

K10.3

ICD-10 Finland

Alveolitis of jaws

2.8

24.9

163

595

SPAT1211

SPAT

Application of soft bandage

2.2

24.9

268

1278

R03BA02

ATC

budesonide; inhalant

1.8

24.8

477

2851

A01

ICPC

Pain general/multiple sites

2.4

24.7

216

932

F13.24

ICD-10 Finland

Addiction relationship caused by sedative and hypnotic active addiction

90.9

24.7

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

5.9

24.6

122

R04.2

ICD-10 Finland

Haemoptysis

3.5

24.6

119

352

J01FA06

ATC

roxithromycin; oral

1.5

24.6

1094

8219

F13.25

ICD-10 Finland

Addiction caused by sedative and hypnotic continuous use

43.2

24.6

E66.00

ICD-10 Finland

Metabolic syndrome

2.6

24.5

190

766

F31

ICD-10 Finland

Bipolar affective disorder

7.0

24.5

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.8

24.4

432

2510

R03AK08

ATC

formoterol and beclometasone; inhalant

3.2

24.2

134

438

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.6

24.2

685

4594

S97

ICPC

Chronic ulcer skin

2.8

24.1

162

601

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.3

24.0

228

1026

SPAT1262

SPAT

Handing over of treatment supplies

1.8

24.0

494

3016

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.7

23.9

598

3870

R03DX07

ATC

roflumilast; oral

22.9

23.9

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.2

23.8

249

1170

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.7

23.7

648

4297

EBA30

NOMESCO Finland

Excision of root of tooth

2.6

23.7

177

701

SAA01

NOMESCO Finland

Simple examination of mouth

1.5

23.6

1924

16461

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

3.2

23.5

130

425

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

3.7

23.5

105

291

F41.09

ICD-10 Finland

UNS Panic Syndrome

3.8

23.4

103

282

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.0

23.3

341

1848

PD3YT

NOMESCO Finland

Pelvic artery PTA with stent

7.2

23.3

P72

ICPC

Schizophrenia

4.6

23.3

182

P74

ICPC

Anxiety disorder/anxiety state

3.3

23.3

121

378

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.8

23.3

487

2986

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

6.6

23.3

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

4.4

23.2

201

M03BC01

ATC

orphenadrine (citrate); systemic

1.6

23.2

667

4482

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.0

23.2

310

1619

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.1

23.2

287

1453

F60.9

ICD-10 Finland

Personality disorder, unspecified

6.2

23.2

104

A02BC01

ATC

omeprazole; systemic

1.6

23.1

694

4718

K05.3

ICD-10 Finland

Chronic periodontitis

2.6

23.1

172

679

C09AA05

ATC

ramipril; oral

1.7

23.1

600

3923

Z02.7

ICD-10 Finland

Issue of medical certificate

2.5

23.1

188

781

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.3

23.0

226

1031

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

5.4

23.0

133

3051A

ICD-9 Finland

Nondependent abuse of drugs, Tobacco use disorder

+∞

22.9

103

Kela drug reimbursment

Diabetes, insulin-treated

1.6

22.9

671

4529

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.5

22.9

1086

8236

M54

ICD-10 Finland

Dorsalgia

2.0

22.8

321

1711

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.2

22.8

256

1244

SPAT1059

SPAT

Spirometry at the office

2.6

22.7

169

666

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.7

22.6

512

3209

I71.4

ICD-10 Finland

Abdominal aortic aneurysm, without mention of rupture

4.8

22.6

161

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

3.0

22.6

138

483

R03DC03

ATC

montelukast; oral

1.8

22.6

437

2611

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.8

22.6

153

570

A28

ICPC

Limited function/disability NOS

2.0

22.4

314

1670

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.5

22.4

178

730

X59

ICD-10 Finland

Exposure to unspecified factor

1.7

22.4

502

3140

K04.0

ICD-10 Finland

Pulpitis

2.0

22.4

294

1528

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.5

22.3

1515

12385

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.2

22.3

229

1067

E0000UV

ATC

1.5

22.3

1009

7562

C07AA05

ATC

propranolol; systemic

1.7

22.1

510

3214

A46

ICD-10 Finland

Erysipelas

1.9

22.0

370

2106

N06AA12

ATC

doxepin; systemic

2.7

21.9

154

588

R03AC18

ATC

indacaterol; inhalant

8.2

21.9

NH1BA

NOMESCO Finland

Ankle extensive X-ray examination

3.7

21.8

263

M05BA04

ATC

alendronic acid; oral

2.5

21.8

174

716

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

5.8

21.7

109

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

80.7

21.7

F19.24

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction

221.6

21.6

P99

ICPC

Psychological disorders other

3.6

21.5

100

287

N05AA01

ATC

chlorpromazine; systemic, rectal

5.1

21.5

135

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

5.4

21.4

123

P03

ICPC

Feeling depressed

2.1

21.4

251

1243

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

6.5

21.4

S22.3

ICD-10 Finland

Fracture of rib

2.3

21.4

201

900

A77

ICPC

Viral disease other/NOS

3.2

21.3

115

371

A04

ICPC

Weakness/tiredness general

2.0

21.2

309

1671

W19

ICD-10 Finland

Unspecified fall

2.1

21.1

239

1165

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.0

21.0

300

1610

F31.8

ICD-10 Finland

Other bipolar affective disorders

4.5

21.0

170

NA1AD

NOMESCO Finland

Cervical spine CT examination

3.1

21.0

120

402

L73.2

ICD-10 Finland

Hidradenitis suppurativa

6.9

21.0

WZA90

NOMESCO Finland

Other doctors statement

1.6

20.9

620

4184

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

2.9

20.9

130

459

GD5AD

NOMESCO Finland

Thorax and upper abdomen combined CT examination of

6.7

20.9

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.1

20.9

243

1200

F15.1

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, harmful use

+∞

20.9

D11

ICPC

Diarrhoea

2.0

20.8

304

1643

R03BA01

ATC

beclometasone; inhalant

1.8

20.8

378

2209

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.7

20.8

519

3343

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.7

20.8

459

2852

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.6

20.7

580

3853

NF1AA

NOMESCO Finland

Hip X-ray examination

2.2

20.7

219

1036

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

4.8

20.6

146

JN4AD

NOMESCO Finland

Body CT examination

2.2

20.6

213

999

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

6.6

20.5

SPAT1273

SPAT

Structured assessment of psychoactive substance / tobacco use

3.0

20.5

121

415

WX882

NOMESCO Finland

High dependency care

3.4

20.5

100

299

R03AC13

ATC

formoterol; inhalant

2.6

20.5

152

599

L08

ICPC

Shoulder symptom/complaint

1.7

20.4

491

3128

E000001

ATC

1.7

20.2

536

3506

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.9

20.2

123

430

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.8

20.2

349

2004

P01

ICPC

Feeling anxious/nervous/tense

2.0

20.2

259

1330

A03FA01

ATC

metoclopramide; systemic, rectal

1.7

20.2

534

3493

JN4BD

NOMESCO Finland

Extensive body CT

2.0

20.2

289

1551

SAA03

NOMESCO Finland

Extended examination of mouth

1.5

20.2

1008

7678

H25.8

ICD-10 Finland

Other senile cataract

2.2

20.1

215

1022

E87.6

ICD-10 Finland

Hypokalaemia

3.5

20.1

288

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

6.2

20.0

Z00.0

ICD-10 Finland

General medical examination

1.7

20.0

472

2990

SGA01

NOMESCO Finland

Tooth opening as first aid

1.7

19.8

457

2873

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

2.4

19.7

178

780

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

2.0

19.6

267

1403

F11.29

ICD-10 Finland

Addiction caused by opiates UNS

201.3

19.6

F51.0

ICD-10 Finland

Nonorganic insomnia

1.8

19.4

344

1991

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.6

19.4

548

3640

130

Kela drug reimbursment

Malignant tumour

2.1

19.3

225

1110

S01.0

ICD-10 Finland

Open wound of scalp

2.2

19.3

199

930

L02.3

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of buttock

3.8

19.3

224

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

3.1

19.1

109

364

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.7

19.1

407

2496

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

2.0

19.1

247

1275

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

3.0

19.0

109

367

SPAT1058

SPAT

PEF monitoring instruction

2.1

18.9

230

1155

W0A12

NOMESCO Finland

Planned therapy visit for psychiatric disease

9.6

18.8

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

3.1

18.8

107

357

N05AC02

ATC

thioridazine; oral

3.9

18.6

201

3018D

ICD-9 Finland

Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]

9.0

18.6

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

2.1

18.6

226

1136

F12.1

ICD-10 Finland

Mental and behavioural disorders due to use of cannabinoids, harmful use

191.2

18.5

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.9

18.5

272

1470

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.9

18.5

272

1474

D64.9

ICD-10 Finland

Anaemia, unspecified

2.1

18.4

229

1160

SPAT1247

SPAT

Outpatient detoxication and monitoring

9.2

18.3

N03AF01

ATC

carbamazepine; oral, rectal

2.5

18.2

148

613

J01CE02

ATC

phenoxymethylpenicillin; oral

1.4

18.1

1859

16154

XQ802

NOMESCO Finland

Epicutan test

2.6

18.1

132

517

SPAT1307

SPAT

Psychosocial counselling and guidance

2.4

18.1

162

706

P18

ICPC

Medication abuse

14.4

18.1

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.9

18.1

284

1576

M03BX02

ATC

tizanidine; oral

1.4

18.0

1698

14509

M01AE02

ATC

naproxen; oral, rectal

1.4

18.0

1503

12558

R42

ICD-10 Finland

Dizziness and giddiness

1.6

17.9

491

3231

R63.4

ICD-10 Finland

Abnormal weight loss

3.1

17.9

320

3050A

ICD-9 Finland

Nondependent abuse of drugs, Alcohol abuse

6.4

17.9

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

2.4

17.9

158

685

TGC00

NOMESCO Finland

Bronchial lavation

3.4

17.9

266

UJF32

NOMESCO Finland

Coloscopy

1.5

17.8

627

4394

Z97.2

ICD-10 Finland

Presence of dental prosthetic device (complete)(partial)

3.5

17.8

251

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

6.5

17.8

ZXH06

SPAT

3.4

17.7

268

D82

ICPC

Teeth/gum disease

1.5

17.7

905

6879

R32

ICD-10 Finland

Unspecified urinary incontinence

3.8

17.6

206

R07.3

ICD-10 Finland

Other chest pain

2.0

17.6

248

1321

R03BB07

ATC

umeclidinium bromide; inhalant

7.5

17.6

S76

ICPC

Skin infection other

2.4

17.6

151

646

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

2.0

17.6

245

1299

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.5

17.5

139

571

XG405

NOMESCO Finland

Education on PEF monitoring

4.7

17.5

131

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

4.8

17.4

123

SXA20

NOMESCO Finland

Local application of medicine to mouth

2.3

17.4

169

769

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

4.0

17.4

174

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

2.4

17.4

150

644

Z04.3

ICD-10 Finland

Examination and observation following other accident

3.6

17.4

219

L16

ICPC

Ankle symptom/complaint

1.9

17.3

253

1364

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.6

17.3

533

3615

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

2.5

17.3

142

593

SPF00

NOMESCO Finland

Repatation of teeth prosthesis

3.4

17.2

258

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.6

17.2

132

532

K03.66

ICD-10 Finland

Tooth plaque

2.3

17.1

169

773

R60.9

ICD-10 Finland

Oedema, unspecified

2.6

17.1

129

515

N05AF01

ATC

flupentixol; systemic

4.5

17.1

139

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

6.7

17.1

SDE04

NOMESCO Finland

Periodontal treatment by dental hygienist, very extensive

1.9

17.0

280

1577

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.6

16.9

475

3144

A41.9

ICD-10 Finland

Sepsis, unspecified

3.0

16.9

339

SPAT1272

SPAT

Drug screening

14.1

16.8

SPA00

NOMESCO Finland

Changing form of teeth in prepation for prothetic work

2.5

16.7

133

546

F41.00

ICD-10 Finland

Moderate panic disorder

4.5

16.7

133

3018X

ICD-9 Finland

Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]

8.1

16.7

XX3DW

NOMESCO Finland

Time consuming IT work

1.9

16.7

276

1556

F19.25

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances continuously used

+∞

16.7

F19.2

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, dependence syndrome

+∞

16.7

A02BC05

ATC

esomeprazole; systemic

1.4

16.7

1027

8071

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.8

16.6

106

382

WZC00

SPAT

2.5

16.6

129

523

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.5

16.6

716

5238

SBA00

NOMESCO Finland

Microbiological examinations

3.4

16.6

244

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.9

16.5

251

1374

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

5.1

16.5

104

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

9.5

16.4

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.6

16.4

124

496

L12

ICPC

Hand/finger symptom/complaint

1.7

16.3

347

2123

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

3.6

16.3

210

V03AB30

ATC

7.2

16.3

D73

ICPC

Gastroenteritis presumed infection

3.0

16.2

313

N05CF02

ATC

zolpidem; oral

1.6

16.2

444

2919

C10AA05

ATC

atorvastatin; oral

1.4

16.1

901

6937

N06AB08

ATC

fluvoxamine; oral

3.1

16.1

293

A01AB09

ATC

miconazole; local oral

2.0

16.1

218

1142

I25.2

ICD-10 Finland

Old myocardial infarction

2.3

16.1

158

723

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

3.4

16.1

228

GDA98

NOMESCO Finland

Other bronchoscopic incision, excision of lesion or repair of lung

7.6

16.1

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.4

16.1

1073

8541

C10AA01

ATC

simvastatin; oral

1.4

16.0

969

7574

J96.0

ICD-10 Finland

Acute respiratory failure

5.8

16.0

F05.9

ICD-10 Finland

Delirium, unspecified

5.0

16.0

104

8140/3-C34.1

ICD-O-3

Adenocarcinoma, NOS, of upper lobe, lung

8.6

15.9

R03AC12

ATC

salmeterol; inhalant

2.6

15.9

117

460

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

3.2

15.9

258

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.9

15.8

229

1232

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

4.4

15.7

128

F40.1

ICD-10 Finland

Social phobias

3.8

15.7

176

F20.09

ICD-10 Finland

Paranoid schizophrenia UNS

6.5

15.7

F13.3

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, withdrawal state

+∞

15.6

D35.0

ICD-10 Finland

Benign neoplasm: Adrenal gland

4.1

15.5

153

C08CA01

ATC

amlodipine; oral

1.4

15.5

804

6090

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

2.5

15.5

120

487

TPH04

NOMESCO Finland

Cathetrisation of vein

1.6

15.5

511

3512

F19.9

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, unspecified mental and behavioural disorder

160.8

15.5

R52.2

ICD-10 Finland

Other chronic pain

2.8

15.4

100

366

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.3

15.4

139

610

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.3

15.4

144

642

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.5

15.4

124

513

WX725

NOMESCO Finland

Noninvasive ventilation

2.4

15.4

136

591

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.2

15.3

167

801

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

4.6

15.3

118

F41.0

ICD-10 Finland

Panic disorder [episodic paroxysmal anxiety]

3.5

15.3

206

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.9

15.3

241

1339

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

4.5

15.2

123

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

2.9

15.2

321

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.9

15.1

234

1290

N05BB01

ATC

hydroxyzine; systemic

2.1

15.1

165

792

N05AF05

ATC

zuclopenthixol; systemic

4.9

15.1

102

T82

ICPC

Obesity

2.6

15.1

113

451

DQB10

NOMESCO Finland

Endoscopic excision of lesion of larynx

5.0

15.0

J10.0

ICD-10 Finland

Influenza with pneumonia, seasonal influenza virus identified

5.6

14.9

O04.9

ICD-10 Finland

Medical abortion, complete or unspecified, without complication

2.1

14.9

179

894

L01

ICPC

Neck symptom/complaint

1.7

14.9

330

2043

WW200

SPAT

1.8

14.9

287

1703

P06

ICPC

Sleep disturbance

1.8

14.8

246

1387

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.9

14.8

222

1210

Y04.9

ICD-10 Finland

Assault by bodily force by unknown person

5.5

14.8

R13

ICD-10 Finland

Dysphagia

2.1

14.7

162

779

N06AX26

ATC

vortioxetine; oral

2.2

14.7

150

698

UKC02

NOMESCO Finland

Cystoscopy

1.6

14.7

367

2347

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.4

14.6

1376

11563

R03AL04

ATC

indacaterol and glycopyrronium bromide; inhalant

7.7

14.6

JN4CD

NOMESCO Finland

Very extensive body CT

2.5

14.6

113

459

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

7.1

14.6

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

4.2

14.4

130

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.8

14.4

278

1649

SGA02

NOMESCO Finland

Opening and dilatation of root canal of tooth

1.7

14.4

332

2076

ZZH21

NOMESCO Finland

Graft of patients own bone, small pieces

3.2

14.4

238

R11

ICD-10 Finland

Nausea and vomiting

2.0

14.3

184

946

2968A

ICD-9 Finland

Affective psychoses, Manic-depressive psychosis, other and unspecified

5.8

14.3

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.2

14.3

150

708

IGY02

SPAT

6.6

14.3

E66.8

ICD-10 Finland

Other obesity

2.2

14.3

152

721

WX002

NOMESCO Finland

Sedation and analgesia

1.6

14.3

460

3140

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

7.2

14.3

IEV99

SPAT

27.3

14.3

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

3.7

14.2

166

SPE90

NOMESCO Finland

Other fitting and preparation of partial tooth prosthesis

3.3

14.2

213

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.6

14.2

104

409

F32.1

ICD-10 Finland

Moderate depressive episode

2.2

14.2

150

711

D07AC01

ATC

betamethasone; topical

1.4

14.2

835

6459

SPAT1275

SPAT

Drug rehabilitation and replacement therapy of opioid-dependent person

9.1

14.2

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.1

14.1

167

830

I50.0

ICD-10 Finland

Congestive heart failure

2.3

14.1

138

629

N01

ICPC

Headache

1.8

14.1

242

1384

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.4

14.1

119

506

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

3.2

14.0

237

W0A10

NOMESCO Finland

Mapping of psychosocial situation

14.5

14.0

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.6

14.0

371

2406

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

2.9

14.0

294

R51

ICD-10 Finland

Headache

2.2

14.0

140

645

OAB42

SPAT

2.2

14.0

140

645

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

2.0

14.0

191

1004

R05

ICD-10 Finland

Cough

1.6

13.9

453

3094

A99

ICPC

Disease/condition unspecnature/site

2.0

13.9

193

1021

PH2CD

NOMESCO Finland

Very extensive CT of inferior vena cava, pelvic veins and veins of lower extremity

6.9

13.9

K13.21

ICD-10 Finland

Leukoplakia caused by tobacco

12.7

13.9

M70.6

ICD-10 Finland

Trochanteric bursitis

1.8

13.9

264

1557

Z75.1

ICD-10 Finland

Person awaiting admission to adequate facility elsewhere

4.4

13.8

112

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

2.6

13.8

101

395

GDC00

NOMESCO Finland

Lobectomy of lung

7.8

13.8

K59.09

ICD-10 Finland

Constipation, unspecified

2.2

13.8

137

631

R52.9

ICD-10 Finland

Pain, unspecified

1.9

13.8

204

1107

R78

ICPC

Acute bronchitis/bronchiolitis

3.2

13.8

224

I70.9

ICD-10 Finland

Generalized and unspecified atherosclerosis

4.2

13.8

122

64091

ICD-8 Finland

Medical termination of pregnancy, Weakness (medical-social reason)

2.4

13.7

112

469

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

5.3

13.7

S42.2

ICD-10 Finland

Fracture of upper end of humerus

2.5

13.7

107

435

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

3.7

13.7

162

D10

ICPC

Vomiting

2.1

13.7

150

722

SPD01

NOMESCO Finland

Mucosa-supported complete denture

6.4

13.7

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.7

13.7

329

2081

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.1

13.6

148

711

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

2.1

13.6

152

738

R50.9

ICD-10 Finland

Fever, unspecified

1.7

13.6

330

2093

J13

ICD-10 Finland

Pneumonia due to Streptococcus pneumoniae

5.4

13.6

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

5.4

13.6

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.3

13.6

122

537

EB1BA

NOMESCO Finland

Extensive intraoral X-ray examination

8.0

13.5

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.0

13.5

186

981

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.1

13.5

149

718

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

2.0

13.5

171

873

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.4

13.5

116

499

N05AL01

ATC

sulpiride; systemic

4.0

13.5

134

SAA04

NOMESCO Finland

Special inverstigation of mouth

2.1

13.5

147

708

2989X

ICD-9 Finland

Other nonorganic psychoses, Unspecified psychosis

5.6

13.4

188

Kela drug reimbursment

Psychosis requiring demanding treatment

4.9

13.4

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

3.4

13.4

186

SPAT1243

SPAT

Psychiatric/psychological examination

2.9

13.3

281

K04.09

ICD-10 Finland

Pulpit UNS

2.3

13.3

120

529

EJA10

NOMESCO Finland

Biopsy of tongue or floor of mouth

3.3

13.2

209

A03

ICPC

Fever

1.6

13.2

389

2592

C03DA01

ATC

spironolactone; oral

1.8

13.2

232

1336

M48.0

ICD-10 Finland

Spinal stenosis

1.7

13.1

273

1656

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

6.9

13.1

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

2.6

13.1

384

PA7BD

NOMESCO Finland

CT angiography of neck and brain

3.6

13.1

168

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.7

13.1

325

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.0

13.0

176

923

IGY02

NOMESCO Finland

Psychiatric monitoring contact

3.5

13.0

169

R28

ICPC

Limited function/disability (R)

4.3

13.0

110

D01

ICPC

Abdominal pain/cramps general

1.8

13.0

248

1465

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.3

13.0

124

562

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.4

13.0

663

4978

SXB00

NOMESCO Finland

Removeal of sutres from oral mucosa

2.0

13.0

167

860

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

3.2

12.9

218

ICB03

SPAT

9.4

12.9

SPE01

NOMESCO Finland

Mucosa-supported partial denture

4.0

12.9

130

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

12.9

923

7362

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

3.1

12.9

236

NHJ10

NOMESCO Finland

Internal fixation of fracture of ankle using wire, rod, cerclage or pin

2.3

12.8

120

539

SPAT1172

SPAT

Guidance concerning hydration

3.8

12.8

141

M01AB05

ATC

diclofenac; systemic, rectal

1.3

12.8

1747

15417

Z04.4

ICD-10 Finland

Examination and observation following alleged rape and seduction

9.7

12.7

SDA04

NOMESCO Finland

Very demanding parodonthologic therapy

1.4

12.7

609

4516

B86

ICD-10 Finland

Scabies

3.7

12.7

152

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

5.3

12.7

SPAT1238

SPAT

Brief therapy

3.4

12.7

178

F99

ICD-10 Finland

Mental disorder, not otherwise specified

3.2

12.7

205

N06AA10

ATC

nortriptyline; systemic

3.0

12.6

249

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.9

12.6

185

1000

L86

ICPC

Back syndrome with radiating pain

2.1

12.6

145

712

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.5

12.6

406

2766

R03BA08

ATC

ciclesonide; inhalant

1.8

12.6

211

1196

IGY99

NOMESCO Finland

Other psychiatric treatment contact

3.8

12.6

138

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

2.2

12.6

131

619

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

3.3

12.5

196

R03BB06

ATC

glycopyrronium bromide; inhalant

8.2

12.5

F13.09

ICD-10 Finland

Intoxication caused by sedative and hypnotic UNS

+∞

12.5

F19.09

ICD-10 Finland

Intoxication caused by several drugs in combination and by other psychoactive substances UNS

+∞

12.5

K86.08

ICD-10 Finland

Alcohol-induced chronic pancreatitis

6.7

12.5

K92.0

ICD-10 Finland

Haematemesis

3.0

12.4

239

PEF23

NOMESCO Finland

Thrombendarterectomy of femoral artery

4.1

12.4

120

A08

ICPC

Swelling

2.5

12.4

409

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

2.7

12.4

306

N06BA04

ATC

methylphenidate; oral

3.5

12.4

166

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.1

12.3

139

680

9694A

ICD-9 Finland

Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers

6.5

12.3

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.8

12.2

227

1328

Z72.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3022313) Gas panel - Capillary blood

553

1110

5.78

268.31

5.0

3.5

—

(3009343) pH of Capillary blood

646

1538

4.98

257.33

4.9

3.4

7.4

0.90

202

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

649

1563

4.92

254.82

5.0

3.4

5.4

5.1

kpa

6.64

609

1450

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

628

1477

5.02

253.66

4.9

3.4

1.7

mmol/l

0.01

509

1097

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

493

962

5.85

245.73

5.2

3.7

24.9

24.8

mmol/l

0.33

467

896

(3019225) pH of Specimen

776

2523

3.71

199.71

5.1

4.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

884

3275

3.32

183.79

4.8

4.3

29.9

31.8

4.89

627

2270

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1967

11667

2.70

164.56

9.0

6.0

1.2

mmol/l

0.28

1774

10625

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1300

6571

2.61

146.81

2.9

2.3

—

(3023368) Bacteria identified in Blood by Culture

1334

6896

2.57

142.90

4.7

4.4

—

(42870588) Differential panel, method unspecified - Blood

1589

9108

2.43

133.59

6.8

6.0

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

899

4048

2.68

125.30

2.2

1.8

—

(3013512) EKG study

1381

7639

2.39

123.20

4.5

3.6

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2101

13974

2.38

121.19

7.1

6.3

9.0

11.5

umol/l

18.70

1984

13295

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1640

9854

2.32

119.67

4.7

3.3

67.8

47.9

ng/l

0.36

1215

6426

(3013826) Glucose [Moles/volume] in Serum or Plasma

2266

15802

2.38

113.68

6.6

4.7

6.8

6.7

mmol/l

1.63

2158

14775

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

375

1069

3.83

113.55

2.2

1.9

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1457

8466

2.29

113.41

3.4

2.6

51.8

58.3

u/l

7.83

1324

7865

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

808

3604

2.64

113.41

2.4

1.7

1.5

14.20

687

3207

(3044640) Blood type and Crossmatch panel - Blood

1462

8536

2.28

112.15

3.0

2.4

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

350

978

3.88

108.92

2.1

1.8

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

319

842

4.09

107.46

3.4

2.7

—

(3013115) Eosinophils [#/volume] in Blood

2079

14175

2.26

107.02

7.5

6.1

0.2

e9/l

3.38

1863

12541

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1936

12836

2.23

106.67

8.8

6.8

1.2

mmol/l

0.27

1665

10871

(3001604) Monocytes [#/volume] in Blood

2016

13633

2.23

105.08

7.1

5.9

0.7

0.6

e9/l

31.57

1825

11867

(3006315) Basophils [#/volume] in Blood

2022

13695

2.23

104.91

7.1

5.9

0.0

e9/l

20.07

1829

11915

(3028707) Methadone [Presence] in Urine by Screen method

191

350

5.73

99.89

7.5

1.5

—

(4010399)

509

1905

2.98

98.83

1.5

1.4

—

(3019198) Lymphocytes [#/volume] in Blood

2038

14046

2.18

98.42

7.2

5.9

2.1

1.9

e9/l

2.62

1839

12466

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1213

6897

2.20

95.60

3.3

2.9

1587.7

1141.2

ng/l

2.40

1010

5845

(3013650) Neutrophils [#/volume] in Blood by Automated count

2202

15818

2.18

93.18

11.3

9.2

4.9

4.1

e9/l

53.84

2019

13875

(3019309) Folate [Moles/volume] in Red Blood Cells

861

4334

2.33

90.35

1.9

1.7

1039.6

1173.0

nmol/l

4.29

641

3328

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2683

21028

2.47

89.93

10.0

7.6

80.3

77.2

u/l

3.49

2540

19879

(3032080) INR in Blood by Coagulation assay

1622

10513

2.07

88.73

6.3

8.5

1.1

1.2

inr

2.95

353

3094

(3019069) Monocytes/100 leukocytes in Blood

1871

12814

2.06

87.49

7.6

6.4

8.2

8.6

5.77

1749

12059

(3019060) Gas panel - Arterial blood

456

1713

2.93

87.36

6.1

5.1

—

(3006504) Eosinophils/100 leukocytes in Blood

1854

12733

2.04

85.09

7.1

6.1

2.6

2.9

5.79

1719

11917

(3003396) Base excess in Arterial blood by calculation

649

2970

2.47

83.70

8.2

7.9

1.4

1.0

mmol/l

1.87

553

2308

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

649

2987

2.46

82.56

8.3

7.8

5.5

5.1

kpa

11.96

625

2852

(3027801) Oxygen [Partial pressure] in Arterial blood

649

2988

2.46

82.49

8.3

7.8

10.2

12.5

kpa

31.69

628

2852

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1299

7947

2.05

81.32

2.5

2.2

252.4

211.7

u/l

0.35

1220

7487

(3002030) Lymphocytes/100 leukocytes in Blood

1889

13193

2.01

81.10

7.3

6.2

25.9

28.3

17.86

1738

12360

(3022096) Basophils/100 leukocytes in Blood

1795

12373

1.99

79.35

7.2

6.2

0.7

0.63

1666

11594

(3018010) Neutrophils/100 leukocytes in Blood

1855

13020

1.97

76.79

7.0

6.0

59.6

57.0

18.54

1724

12249

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

381

1417

2.91

73.79

1.9

1.6

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

518

2254

2.54

73.69

7.1

7.4

1.4

mmol/l

0.98

497

2172

(3016502) Oxygen saturation in Arterial blood

581

2686

2.41

72.38

8.6

8.3

93.6

95.8

11.72

567

2585

(3011288) Drugs identified in Urine by Screen method

217

577

3.95

71.82

10.0

1.6

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

808

4325

2.15

70.61

3.6

0.8

mmol/l

2.97

745

4084

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

276

883

3.32

69.13

2.2

2.5

470.2

496.8

ug/l

0.07

257

833

(4034850)

275

886

3.29

68.08

11.1

9.2

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

1638

11314

1.89

68.05

5.3

5.0

34.4

35.8

g/l

18.23

1500

10576

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

359

1355

2.85

67.43

7.7

10.4

24.9

24.2

mmol/l

3.45

320

1281

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

153

339

4.68

64.21

1.2

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

226

679

3.50

62.40

7.0

1.3

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

653

3391

2.15

60.64

7.0

6.3

1.0

mmol/l

0.32

599

3186

(3000991) Gas panel - Venous blood

467

2117

2.40

60.03

9.4

9.0

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

525

2509

2.30

59.75

2.5

2.3

0.2

g/l

0.21

487

2353

(3021960) Folate [Moles/volume] in Serum or Plasma

951

5712

1.93

58.71

1.6

1.5

18.7

20.6

nmol/l

1.97

768

4943

(3042936) Bacteria identified in Isolate by Culture

705

3823

2.07

58.16

2.4

2.1

—

(3002032) Base excess in Venous blood by calculation

487

2280

2.33

58.05

5.5

3.8

2.2

1.9

mmol/l

0.83

413

1849

(3020891) Body temperature

286

1043

2.91

56.96

10.0

4.4

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

8.83

56.53

2.2

1.8

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1493

10421

1.79

56.29

2.2

1.9

97.3

95.8

pmol/l

0.53

881

5561

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

136

306

4.59

55.97

2.4

2.2

31.8

22.8

mg/l

0.89

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1767

12971

1.78

55.90

4.5

4.0

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

482

2284

2.30

55.71

5.6

3.7

6.2

5.8

kpa

9.61

467

2215

(3008757) Leukocyte morphology finding [Identifier] in Blood

127

272

4.82

55.50

2.3

4.4

—

(3002385) Erythrocyte distribution width [Ratio]

1897

23330

0.56

54.65

26.4

16.1

14.1

13.6

39.40

1866

22847

(3013707) Erythrocyte sedimentation rate by Westergren method

2479

20216

1.91

54.47

5.1

4.0

14.1

11.3

mm/h

16.10

2276

18824

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

348

1443

2.58

53.92

1.8

1.5

—

(3003338) MCHC [Mass/volume]

1985

24029

0.56

52.44

29.6

16.7

331.7

333.0

g/l

9.11

1969

23877

(3024354) Oxygen [Partial pressure] in Venous blood

405

1841

2.37

51.32

4.6

2.9

4.8

4.6

kpa

0.61

388

1781

(3016879) Cocaine [Presence] in Urine

238

830

3.01

51.25

7.0

1.3

—

(3031040) Bacteria [#/volume] in Urine by Automated count

2198

17474

1.77

50.01

5.6

4.1

289.3

1327.5

e6/l

1.51

223

(3009508) Creatinine [Moles/volume] in Urine

1248

8477

1.76

49.99

4.5

3.1

7.4

8.0

mmol/l

3.86

1008

7212

(3007853) Bacteria identified in Skin by Aerobe culture

584

3119

2.06

49.42

2.2

1.7

—

(4198724)

8.97

48.46

2.6

1.3

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

124

293

4.36

47.96

1.6

1.5

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

124

293

4.36

47.96

1.6

1.5

—

(4015189)

9.21

47.81

2.4

2.8

—

(3022217) INR in Platelet poor plasma by Coagulation assay

591

3207

2.03

47.72

18.9

22.4

1.1

1.3

inr

4.11

472

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

144

382

3.90

47.67

1.4

1.3

26.3

26.4

u/l

0.01

109

312

(3005988) Vibrio sp identified in Specimen by Organism specific culture

124

295

4.33

47.54

1.6

1.5

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

124

297

4.30

47.13

1.6

1.5

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

125

302

4.26

46.97

1.6

1.5

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

989

6412

1.77

45.68

2.4

2.1

3.2

2.9

mg/l

3.51

812

5499

(3024522) Salmonella sp identified in Specimen by Organism specific culture

123

301

4.21

45.45

1.6

1.5

—

(1761868) Lipid panel - Serum or Plasma

673

10710

0.53

45.13

2.7

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

138

370

3.85

44.99

6.5

5.4

365.3

370.6

umol/l

0.15

127

328

(3014576) Chloride [Moles/volume] in Serum or Plasma

596

3307

1.98

44.94

9.8

7.3

103.1

104.5

mmol/l

7.62

586

3242

(3042631) Mycobacterium sp identified in Specimen

130

336

3.99

44.62

3.2

2.8

—

(3000764) Benzodiazepines [Presence] in Urine

238

899

2.78

44.17

7.1

1.3

—

(3004616) Nuclear Ab [Presence] in Serum

131

344

3.92

43.98

1.5

1.2

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

481

2505

2.08

43.14

2.3

2.2

364.3

370.0

nmol/l

0.20

433

2326

(3028300) Cannabinoids [Presence] in Urine

238

911

2.74

43.04

7.1

1.3

—

(3027008) Opiates [Presence] in Urine

237

906

2.74

42.97

7.0

1.3

—

(3017732) Neutrophils [#/volume] in Blood

393

1926

2.18

41.18

2.8

2.9

5.0

4.1

e9/l

6.85

233

1549

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

577

3268

1.93

40.59

5.8

6.4

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

504

2739

1.99

39.97

2.1

1.7

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2303

19062

1.69

39.95

5.2

3.1

65.3

48.2

u/l

7.86

2128

17916

(3020779) Urea [Moles/volume] in Serum or Plasma

449

2343

2.06

39.86

8.7

8.1

8.7

9.5

mmol/l

1.61

429

2244

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

249

1018

2.56

39.41

2.1

1.6

1.8

ug/l

0.11

224

919

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

524

2900

1.96

39.38

2.7

4.6

225.1

245.2

u/l

3.01

474

2760

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

121

326

3.81

39.18

1.6

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

217

4.48

38.37

1.5

1.4

1.5

1.3

promille

0.45

169

(3017354) Segmented neutrophils/100 leukocytes in Blood

100

239

4.28

38.12

2.3

4.0

58.4

56.3

0.36

162

(3015235) Bicarbonate [Moles/volume] in Capillary blood

177

633

2.90

36.31

3.8

2.9

25.9

24.8

mmol/l

2.27

159

551

(3023183) Ammonium ion [Moles/volume] in Plasma

165

575

2.97

35.46

2.2

3.0

29.2

35.5

umol/l

3.26

135

500

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

261

1147

2.38

35.28

4.6

2.6

0.7

0.42

248

1098

(3018405) Lactate [Moles/volume] in Arterial blood

225

928

2.53

34.91

8.6

3.9

1.4

mmol/l

0.33

225

913

(3027944) Amphetamines [Presence] in Urine

219

893

2.56

34.80

5.8

1.3

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

1193

8661

1.59

33.39

3.2

3.4

2.4

mmol/l

0.48

960

7670

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

212

4.24

33.22

1.2

—

3.6

—

(3003181) Sodium [Moles/volume] in Urine

130

410

3.26

33.12

1.6

1.3

53.8

65.3

mmol/l

2.23

334

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1432

10865

1.56

32.94

2.6

2.2

69.3

76.5

nmol/l

17.79

1241

9899

(3002173) Hemoglobin [Mass/volume] in Arterial blood

450

2507

1.92

32.76

10.2

8.7

124.6

123.1

g/l

0.80

441

2410

(3043409) Potassium [Moles/volume] in Arterial blood

197

789

2.59

32.46

9.4

4.2

3.9

mmol/l

0.36

190

745

(3023520) Reticulocytes [#/volume] in Blood

389

2073

1.99

32.22

2.7

74.8

71.1

e9/l

1.36

304

1562

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

482

2765

1.87

32.02

2.1

1.8

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1150

8344

1.58

31.91

4.4

4.0

14.5

8.7

mg/mmol

2.83

745

5377

(3037467) Urinalysis macro (dipstick) panel - Urine

2212

18576

1.58

31.73

5.6

4.1

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

349

1806

2.04

31.35

1.8

1.7

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

12.03

30.76

1.7

1.3

40.5

49.2

umol/l

0.50

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

461

2641

1.87

30.67

2.9

4.3

9.0

29.8

ug/l

2.61

413

2138

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

259

1204

2.25

30.64

6.1

3.9

24.3

24.2

mmol/l

0.07

212

1086

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

884

6092

1.62

30.14

1.9

1.8

1.1

mg/l

0.04

681

4648

(3012516) Albumin [Mass/volume] in Urine

1097

7960

1.57

29.99

3.8

3.3

145.9

287.3

mg/l

1.20

707

5118

(3017143) Hepatitis C virus Ab [Presence] in Serum

532

3207

1.79

29.92

1.8

1.6

—

(3026008) Bacteria identified in Urine by Culture

1006

7182

1.58

29.40

3.2

2.9

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

148

542

2.81

29.05

1.6

1.4

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

302

1527

2.08

28.82

4.5

3.1

130.0

130.2

g/l

0.05

294

1486

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3019

27748

2.02

28.46

23.8

13.3

24.5

23.2

mg/l

1.17

2722

21769

(3022948) Iron [Moles/volume] in Serum or Plasma

637

4093

1.69

28.38

2.9

2.5

12.7

13.7

umol/l

2.46

593

3821

(3004809) Band form neutrophils/100 leukocytes in Blood

123

414

3.05

28.11

2.3

3.6

1.1

1.4

0.55

335

(44816559) Phosphatidylethanol [Mass/volume] in Blood

144

529

2.80

28.10

1.5

1.3

—

(3027945) Reticulocytes/100 erythrocytes in Blood

467

2759

1.81

27.97

2.6

2.0

1.8

2.92

409

2466

(21494755) Public health laboratory ask at order entry panel

116

3054

0.36

27.91

1.3

1.4

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

168

671

2.58

27.83

1.4

1.3

—

(40761535) Cells panel - Urine sediment

385

2153

1.89

27.46

3.6

3.3

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

591

3758

1.70

27.27

3.0

2.5

2.4

2.3

g/l

0.39

543

3513

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

641

4175

1.66

26.98

1.9

1.6

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

313

1642

2.00

26.94

13.6

7.3

25.6

24.5

mmol/l

4.28

300

1522

(4146454)

276

3.48

26.85

2.6

—

(3023419) Bacteria identified in Sputum by Culture

107

343

3.19

26.57

2.2

2.6

—

(3037522) Nuclear Ab [Titer] in Serum

596

3839

1.67

26.09

1.4

1.3

354.9

531.7

titre

4.15

126

780

(3042517) Benzodiazepines panel - Urine

34.75

24.26

2.6

1.4

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

5.22

24.08

3.1

2.1

146.9

162.5

nmol/l

0.45

(3000494) Fungus identified in Specimen by Culture

525

3336

1.68

24.03

1.7

1.5

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

203

944

2.23

23.94

2.6

2.2

5935.5

5105.7

u/l

0.14

369

(46235355) HIV 1 and 2 tests - Meaningful Use set

725

5018

1.57

23.37

2.1

1.8

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

106

4.87

23.16

1.4

1.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

106

4.87

23.16

1.4

1.5

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

767

5409

1.54

22.65

1.6

1.7

430.1

34808751.1

pmol/l

4.76

620

4565

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

242

3.41

22.56

1.5

1.8

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

242

3.41

22.56

1.5

1.8

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

242

3.41

22.56

1.5

1.8

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

540

3519

1.64

22.28

3.2

2.6

21.8

23.8

2.41

472

3028

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2388

21038

1.49

22.08

4.6

3.9

15.0

14.7

pmol/l

5.49

2112

19327

(3009445) Proteinase 3 Ab [Units/volume] in Serum

230

1162

2.05

21.90

1.2

1.6

7.7

18.9

u/ml

—

(3032057) Clostridioides difficile [Presence] in Stool

7.17

21.62

1.7

2.2

—

(3028626) Oxygen [Partial pressure] in Capillary blood

133

538

2.53

21.48

3.5

2.7

7.9

8.1

kpa

0.98

123

491

(3033658) Prothrombin time (PT) actual/Normal

933

6936

1.48

21.18

4.8

3.9

93.2

91.2

1.52

909

6768

(4035726)

392

2382

1.73

20.99

1.3

1.4

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

322

1851

1.82

20.84

5.2

4.0

101.7

88.9

ng/l

1.11

282

1637

(3019550) Sodium [Moles/volume] in Serum or Plasma

3043

28477

1.87

20.77

26.3

14.9

139.0

139.7

mmol/l

34.03

2972

27803

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

133

4.19

20.74

1.4

—

(3009542) Hematocrit [Volume Fraction] of Blood

2340

25794

0.68

20.57

21.8

14.0

39.6

40.3

2.37

1418

19312

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

130

4.21

20.49

1.4

—

(3000492) Spirometry study

445

2818

1.67

20.42

1.6

1.4

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

109

410

2.72

20.39

1.1

1.5

g/l

0.31

367

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

470

3037

1.64

19.90

2.7

2.0

—

(3037121) Protein [Mass/volume] in Urine

184

887

2.14

19.83

4.1

3.1

0.4

0.3

g/l

0.57

372

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

430

2724

1.67

19.66

2.7

1.9

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

101

4.60

19.60

3.4

2.5

141.4

181.9

umol/l

0.33

(3023103) Potassium [Moles/volume] in Serum or Plasma

3044

28575

1.83

19.33

26.0

15.0

4.0

mmol/l

14.64

2965

27857

(3018677) aPTT in Platelet poor plasma by Coagulation assay

595

4099

1.55

19.16

2.3

2.1

30.1

29.8

0.34

576

3988

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

215

1113

2.00

19.12

1.7

1.8

1.7

1.5

g/l

2.24

192

959

(3000570) Elastase.pancreatic [Mass/mass] in Stool

162

754

2.21

19.07

1.4

277.7

285.2

ug/g

0.18

439

(3044889) 12 lead EKG panel

1674

19448

0.72

18.99

4.0

3.6

—

(3028026) IgM [Mass/volume] in Serum or Plasma

288

1655

1.81

18.62

1.7

1.9

1.3

1.4

g/l

0.36

263

1517

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

118

4.20

18.60

1.0

1.1

9.2

7.3

u/ml

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

140

3.90

18.57

1.6

2.1

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

140

3.90

18.57

1.6

2.1

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

140

3.90

18.57

1.6

2.1

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

140

3.90

18.57

1.6

2.1

—

(3008295) Osmolality of Serum or Plasma

273

3.02

18.56

1.3

1.4

276.6

280.8

mosm/kgh2o

0.77

217

(3005322) IgE [Units/volume] in Serum or Plasma

305

1786

1.78

18.51

1.4

1.3

393.1

213.5

u/ml

1.56

289

1646

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

5.74

18.04

1.5

1.4

0.4

ug/l

0.11

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2754

25299

1.53

18.01

5.8

4.6

1.8

2.1

mu/l

2.39

2474

23356

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

4.71

17.97

3.0

3.2

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

5.27

17.48

1.3

1.1

419.9

302.2

pmol/l

0.28

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

177

883

2.06

17.44

2.1

1.8

—

(3014271) Vancomycin [Susceptibility]

4.39

17.31

3.2

2.5

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

128

563

2.32

17.26

2.2

134.4

130.4

g/l

0.79

407

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

112

4.15

17.23

1.7

2.3

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

112

4.15

17.23

1.7

2.3

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

12.20

16.92

1.1

1.0

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

114

4.08

16.84

1.7

2.3

—

(40757494) Bilirubin.total [Moles/volume] in Blood

141

3.73

16.81

2.1

2.3

12.6

30.9

umol/l

—

(3021901) Oxygen saturation in Capillary blood

108

447

2.46

16.68

3.4

2.7

—

(3005719) IgG [Mass/volume] in Serum or Plasma

341

2136

1.67

16.16

2.7

2.8

9.8

10.5

g/l

3.10

310

1954

(3007164) IgA [Mass/volume] in Serum or Plasma

722

5342

1.45

16.09

1.6

1.5

2.5

2.4

g/l

0.08

410

3368

(3004588) Protein electrophoresis panel - Serum or Plasma

286

1718

1.73

15.83

1.7

2.5

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

139

657

2.16

15.78

1.7

1.8

—

(40758558) Short blood count panel - Blood

903

6978

1.40

15.75

7.9

6.6

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1145

9205

1.37

15.73

3.4

3.3

33.6

34.0

u/l

0.06

1068

8776

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

120

3.87

15.72

1.2

1.9

19.5

86.5

ug/l

0.51

106

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

128

587

2.23

15.66

1.3

1.2

2.1

u/ml

—

(3017181) Myelocytes/100 leukocytes in Blood

360

2312

1.63

15.44

3.6

4.3

0.9

0.11

161

637

(3045424) Erythrocytes [Presence] in Urine

111

491

2.30

14.81

1.5

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

134

641

2.14

14.77

1.7

1.8

—

(3020630) Protein [Mass/volume] in Serum or Plasma

327

2080

1.63

14.56

2.1

2.8

65.7

66.6

g/l

1.18

286

1925

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

147

733

2.05

14.53

1.4

1.2

5.0

2.8

u/ml

0.36

(1616796) Gas panel - Central venous blood

122

567

2.20

14.47

5.2

3.8

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

148

743

2.04

14.37

1.4

1.2

3.0

7.2

u/ml

1.29

121

(3002179) Metamyelocytes/100 leukocytes in Blood

331

2123

1.62

14.24

3.5

4.1

0.6

0.02

134

470

(40768797) Stomach Pathology biopsy report

534

3820

1.47

13.99

1.4

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

111

507

2.23

13.75

1.6

1.3

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

9.45

13.44

1.5

1.1

86.2

36.1

mg/l

—

(3026493) Urate [Moles/volume] in Serum or Plasma

930

7384

1.36

13.34

2.8

2.6

892.7

4118.0

umol/l

5.19

795

6509

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

110

507

2.21

13.34

1.6

1.3

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

332

2.51

13.33

1.3

—

nmol/l

—

(3021440) Promyelocytes/100 leukocytes in Blood

336

2203

1.58

13.17

3.7

4.3

0.1

0.98

148

588

(3049717) Cytology report of Urine Cyto stain

178

981

1.86

13.17

2.6

2.5

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

163

876

1.91

13.03

1.8

1.6

0.2

7.3

iu/ml

0.50

169

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

161

2852

0.54

12.99

1.8

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

427

2.29

12.69

1.4

1.5

—

(3026389) Candida sp identified in Specimen by Organism specific culture

334

2.46

12.69

1.4

1.3

—

(3048689) Calprotectin [Mass/mass] in Stool

468

3324

1.48

12.63

2.5

2.4

162.8

138.7

ug/g

0.45

345

2669

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

160

3.16

12.61

1.3

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

106

493

2.19

12.59

1.4

1.6

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

178

3.01

12.32

2.7

2.9

0.3

0.2

e9/l

0.33

161

(3010421) pH of Blood

136

701

1.98

12.31

6.6

4.3

7.4

1.34

112

585

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

184

2.97

12.25

2.7

2.8

578.8

539.6

e6/l

0.22

161

(3007566) Smooth muscle Ab [Titer] in Serum

144

763

1.93

12.03

1.1

1.2

113.3

93.2

titre

0.25

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

115

563

2.08

12.00

1.6

1.5

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

639

4851

1.39

11.91

1.3

36.8

31.3

iu/ml

0.37

173

1553

(3035637) Corticotropin [Mass/volume] in Plasma

340

2.39

11.76

1.4

1.5

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

766

6001

1.36

11.74

1.3

1.2

1.4

1.8

u/ml

0.49

166

1655

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1900

0.47

11.68

1.5

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

9.37

11.65

1.1

1.3

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

379

2.30

11.65

1.2

1.3

0.2

0.4

nmol/l

1.12

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

113

557

2.07

11.59

2.1

3.7

1003.4

812.0

u/ml

0.08

101

516

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

393

2.27

11.56

1.4

1.6

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

290

2.48

11.39

2.0

1.8

—

(3023511) Choriogonadotropin [Units/volume] in Urine

102

488

2.12

11.32

1.5

1.3

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

427

5847

0.69

11.28

2.7

2.9

0.6

0.7

ug/l

2.92

299

3775

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

244

2.61

11.27

3.5

2.5

—

(3018418) pH of Serum or Plasma

939

7629

1.32

11.16

5.2

4.2

7.4

0.00

181

1502

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

106

3.52

11.13

4.4

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

312

2.40

11.09

1.9

1.8

—

(3000475) Leukocytes [#/volume] in Synovial fluid

125

650

1.96

11.06

1.7

7677.5

12276.1

e6/l

1.26

476

(3001019) Free T4 and TSH panel - Serum or Plasma

1614

0.45

10.87

1.4

1.7

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

476

2.11

10.86

1.7

1.9

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

103

3.52

10.86

3.0

2.4

—

(3022145) Colonoscopy Study observation

432

3111

1.45

10.77

1.4

1.3

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

413

2.19

10.68

1.4

1.2

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

604

4624

1.37

10.58

1.3

15.7

10.5

u/ml

0.79

201

1895

(40768804) Tissue Pathology biopsy report

1315

11234

1.28

10.58

2.2

2.0

—

(37021550) Renin [Units/volume] in Plasma --upright

4.18

10.34

1.3

1.4

48.4

65.6

mu/l

0.33

(3052851) Hemolysis interference index of Serum or Plasma

142

789

1.84

10.29

4.2

3.2

—

(3012501) Base excess in Blood by calculation

114

593

1.96

10.11

6.4

4.5

2.9

2.4

mmol/l

0.96

409

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

429

3125

1.43

10.02

2.3

2.8

8.4

8.1

umol/l

0.08

335

2750

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

5.45

9.92

1.1

1.0

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

140

784

1.82

9.90

1.8

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1360

11741

1.27

9.82

3.3

2.8

127.2

130.0

ug/l

0.21

1216

10965

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

132

3.06

9.65

1.1

86.8

81.2

u/l

0.21

101

(3016038) Potassium [Moles/volume] in Urine

148

2.93

9.65

1.4

1.1

28.6

36.6

mmol/l

1.99

135

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

133

3.03

9.53

1.1

25.1

23.1

u/l

0.09

(3017509) Phencyclidine [Presence] in Urine

6.18

9.45

2.9

1.2

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

8.60

9.35

5.2

5.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

3.43

9.31

1.2

1.3

—

(3026782) Osmolality of Urine

646

5089

1.33

9.28

3.2

2.7

473.5

556.1

mosm/kgh2o

19.05

577

4329

(3025159) Blasts/100 leukocytes in Blood

302

2088

1.49

9.25

3.8

4.3

0.0

0.4

0.90

137

497

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

4.16

9.17

2.1

12.8

17.3

umol/l

1.38

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

5.32

9.15

1.2

1.1

—

(3034770) Mitochondria Ab [Titer] in Serum

135

767

1.79

9.13

1.2

942.9

1147.5

titre

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

143

827

1.76

9.11

2.8

3.4

0.4

0.3

u/ml

1.16

458

(3019977) pH of Arterial blood

133

2.96

8.92

2.8

7.4

0.17

(40768446) Kidney Pathology biopsy report

112

3.15

8.91

1.8

1.6

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

225

2.47

8.87

1.1

1.2

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

641

7963

0.76

8.81

3.3

4.0

20.5

21.5

0.90

295

3723

(3000093) Morphology [Interpretation] in Blood Narrative

238

2.42

8.80

1.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

353

2.15

8.76

1.2

1.3

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

147

869

1.72

8.68

1.3

1.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

246

2.38

8.66

4.6

4.1

—

(3044927) Protein electrophoresis panel - Urine

253

2.36

8.60

1.2

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

261

2.32

8.47

1.1

1.0

—

(3015736) pH of Urine

1178

10134

1.25

8.38

3.7

3.1

—

5.7

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

307

2174

1.45

8.33

2.5

2.3

6.8

8.2

ug/l

0.49

251

1962

(40768443) Skin Pathology biopsy report

181

1143

1.62

8.33

1.3

1.2

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

196

2.52

8.30

2.7

2.6

852.0

700.7

e6/l

0.79

(3000850) Epithelial cells [#/volume] in Urine

684

5513

1.30

8.25

2.9

2.5

7.6

5.4

e6/l

3.00

615

4822

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2700

25536

1.31

8.21

7.1

5.5

41.4

39.5

mmol/mol

9.16

2407

23876

(40767503) Oxygen content in Capillary blood by calculation

102

552

1.87

8.10

3.2

2.5

16.7

16.5

0.14

273

(3024980) IgG subclass 4 [Mass/volume] in Serum

444

1.96

7.87

1.3

1.6

0.5

0.8

g/l

2.65

331

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

4.64

7.87

1.1

1.0

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

188

1216

1.58

7.84

1.5

1.9

42.0

39.2

u/l

0.99

154

1086

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

494

1.91

7.83

1.8

1.7

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

121

698

1.76

7.82

1.3

1.2

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

378

2.03

7.73

1.3

1.5

—

(3001556) Androgen free Index in Serum or Plasma

5.38

7.72

1.6

1.2

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

140

2.73

7.60

1.3

44.0

57.9

titre

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

471

1.91

7.59

1.1

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

181

2.51

7.57

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

182

2.49

7.49

1.0

—

(3044009) aPTT.lupus sensitive (LA screen)

5.19

7.44

1.3

1.2

—

(3011412) CD3 cells [#/volume] in Blood

273

2.18

7.25

2.7

2.6

1.4

1.1

e9/l

0.48

169

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

241

2.26

7.24

1.2

1.4

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

292

2105

1.42

7.20

1.4

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2771

26407

1.31

7.20

18.7

12.2

86.7

83.5

ml/min/173m2

11.40

2488

21819

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

5.02

7.18

1.0

1.1

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

742

6141

1.27

7.16

3.8

3.4

—

(36660697) Celiac disease serology panel - Serum

292

2112

1.42

7.07

1.2

—

(3011985) Renin [Units/volume] in Plasma

365

1.99

6.98

1.2

1.4

201.5

56.8

mu/l

0.98

335

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

100

568

1.78

6.86

1.6

1.5

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

254

2.19

6.81

1.3

1.5

28612.4

80010.4

e6/l

1.27

151

(3023199) Leukocytes [#/volume] in Pleural fluid

287

2.11

6.81

1.3

1.5

8236.1

2376.2

e6/l

0.65

206

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

564

4544

1.29

6.71

2.7

3.1

2.5

2.4

mmol/l

3.50

503

3998

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

269

2.14

6.70

1.2

52.0

57.0

u/l

0.35

190

(3006922) Hepatitis E virus Ab [Presence] in Serum

193

2.35

6.64

1.0

1.1

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

366

1.96

6.59

6.2

6.8

11.5

mg/l

0.02

344

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

182

2.38

6.53

1.9

1.2

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

164

2.46

6.51

1.3

1.5

10.9

13.0

u/l

1.64

158

(3039443) Prostate specific Ag panel - Serum or Plasma

706

0.38

6.42

1.1

1.6

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

129

801

1.64

6.42

1.4

1.3

11.1

9.8

u/l

0.48

653

(3017569) Oxygen content in Arterial blood

130

2.63

6.38

3.2

2.3

—

(4062490)

282

2.08

6.33

1.4

—

(3019150) Specific gravity of Urine by Refractometry

683

5671

1.26

6.33

4.4

3.7

1.0

kg/l

0.65

103

803

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

179

2.36

6.30

1.9

1.2

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

120

736

1.65

6.28

1.4

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

191

2738

0.68

6.27

1.3

1.4

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

453

1.83

6.19

1.1

—

(3029937) Albumin [Presence] in Urine by Test strip

839

7144

1.23

6.17

4.1

3.8

0.0

estimate

1.70

247

2491

(3028433) Virus identified in Specimen by Culture

2.92

6.15

1.4

1.2

—

(3030467) Casts [#/volume] in Urine by Automated count

859

7337

1.23

6.13

3.8

3.0

0.6

0.4

e6/l

1.25

665

5493

(3024928) Oxygen saturation in Venous blood

558

1.74

6.12

4.7

2.8

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

280

2.05

6.07

1.3

1.4

2.3

3.0

g/l

2.63

190

(3027135) IgG subclass 1 [Mass/volume] in Serum

280

2.05

6.07

1.3

1.4

6.8

6.7

g/l

0.08

191

(3010144) Erythrocytes [#/volume] in Synovial fluid

267

2.08

6.05

1.5

1.4

57210.2

83751.7

e6/l

0.20

184

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

3.60

6.03

3.5

2.7

—

(3003434) Protein [Mass/volume] in Pleural fluid

310

1.99

5.93

1.3

1.5

36.4

33.2

g/l

1.19

279

(3034274) Bile acid [Moles/volume] in Serum --fasting

304

1.99

5.89

1.6

2.1

11.7

5.3

umol/l

0.39

216

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2809

26965

1.28

5.85

5.5

4.4

6.2

5.9

mmol/l

20.71

2484

24859

(3027456) Digoxin [Moles/volume] in Serum or Plasma

383

1.87

5.80

3.5

3.1

0.9

0.8

nmol/l

0.25

301

(3027923) C peptide [Moles/volume] in Serum or Plasma

161

2.38

5.80

1.4

1.2

nmol/l

0.22

126

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

129

823

1.59

5.78

1.9

1.6

0.2

g/l

0.21

124

782

(40761511) CBC panel - Blood by Automated count

3003

29103

1.35

5.72

22.9

12.4

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

280

2.02

5.71

1.3

1.4

0.4

g/l

0.12

190

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

360

1.88

5.56

1.1

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

4.50

5.51

1.0

1.3

—

(3037756) Immunofixation for Serum or Plasma

508

1.73

5.50

1.5

1.8

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

132

859

1.56

5.46

1.8

1.6

1.2

g/l

0.03

125

815

(3047352) Trisomy 18 risk [Likelihood] in Fetus

524

0.34

5.44

1.4

—

(40760892) CBC W Ordered Manual Differential panel - Blood

737

6272

1.23

5.36

5.5

4.5

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

3.19

5.31

1.2

1.3

271.1

60.9

ug/l

0.64

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

345

1.87

5.28

1.2

1.4

432.6

287.9

pmol/l

1.39

274

(3042733) HLA Ab [Presence] in Serum

102

2.66

5.23

7.3

4.9

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

138

2.41

5.21

1.9

1.3

—

(3019832) Treponema pallidum Ab [Presence] in Serum

328

2543

1.32

5.16

1.8

1.7

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

236

2.05

5.15

1.0

1.1

289.3

285.5

mg/l

0.13

216

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

177

2.22

5.12

2.4

1.7

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

177

2.22

5.12

1.3

1.1

1.0

ratio

0.71

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

5.28

5.04

6.9

8.9

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

243

1811

1.37

4.98

1.3

20.2

50.7

au/ml

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

167

2.23

4.94

1.4

13.1

20.2

u/ml

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

994

0.55

4.86

2.0

1.8

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

603

5077

1.23

4.82

4.3

3.5

478.2

662.1

ng/l

0.37

457

3785

(3043238) Trisomy 21 risk [Likelihood] in Fetus

536

0.39

4.82

1.6

1.5

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

131

2.38

4.81

1.2

1.1

1515.1

1515.5

miu/ml

0.00

131

(3003327) Ova and parasites identified in Stool by Light microscopy

131

878

1.51

4.78

1.9

1.7

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

3047

29690

1.34

4.76

25.5

15.4

77.1

76.8

umol/l

0.14

3047

29681

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

3.58

4.76

12.4

9.5

4.6

6.5

mmol/l

1.63

(3000330) Specific gravity of Urine by Test strip

1248

0.60

4.71

4.3

3.2

—

(3019174) dRVVT (LA screen)

3.95

4.71

1.3

1.2

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

165

2.19

4.65

1.5

1.6

8.7

7.3

u/l

0.10

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

536

4474

1.24

4.64

3.3

2.6

1.3

1.0

e6/l

1.09

321

2539

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

590

1.61

4.58

1.2

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

590

1.61

4.58

1.6

1.4

—

17.0

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

173

2.15

4.56

1.4

1.2

—

(3005033) Fetal Nuchal fold Thickness US

521

0.40

4.54

1.5

1.4

—

(36304419) Bacteria [Presence] in Urine

824

7191

1.19

4.53

3.8

2.9

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

115

759

1.53

4.52

2.3

3.9

45.3

63.2

mg/l

0.92

608

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

113

744

1.54

4.50

2.3

3.8

4.0

2.3

ratio

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

115

761

1.53

4.47

2.3

3.9

38.1

69.6

mg/l

0.93

612

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

198

1455

1.38

4.45

10.6

10.9

—

(3041096) Erythrocytes [Presence] in Urine by Automated

629

7319

0.83

4.40

3.6

3.1

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

258

1985

1.33

4.32

2.5

2.4

27.1

22.5

au/ml

—

118

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.79

4.28

3.0

2.7

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.79

4.28

3.1

2.7

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

102

2.46

4.21

3.1

2.1

249.7

27933.2

u/ml

—

(3012441) Differential panel - Pleural fluid

249

1.90

4.16

1.3

1.5

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

115

2.36

4.15

1.1

1.3

4.3

4.7

umol/l

0.21

109

(40768800) Prostate Pathology biopsy report

610

0.47

4.14

1.1

1.2

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

103

2.44

4.13

2.0

1.3

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

216

1.96

4.06

1.6

1.8

—

(3021788) Differential panel - Synovial fluid

484

1.63

4.03

1.8

1.6

—

(40768806) Pleura Pathology biopsy report

252

1.88

4.02

1.4

1.6

—

(3002582) Erythrocytes [#/volume] in Urine

904

8022

1.17

4.02

3.9

3.1

74.9

97.8

e6/l

0.42

739

6141

(4094501)

824

0.55

4.00

1.1

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

113

765

1.49

3.99

1.8

2.4

37.2

37.9

g/l

0.57

677

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

112

757

1.50

3.98

1.7

1.9

12.6

11.1

mg/l

0.83

102

702

(3040151) Glucose [Moles/volume] in Capillary blood

268

1.84

3.95

2.4

5.7

7.7

7.2

mmol/l

0.37

227

(40760888) Immunoglobulin light chains.free panel - Serum

574

1.57

3.93

2.2

4.0

—

(3044242) Glucose [Moles/volume] in Arterial blood

131

2.22

3.92

3.1

2.1

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

152

1093

1.41

3.92

1.4

1.2

0.5

1.1

u/ml

0.73

(40768441) Liver Pathology biopsy report

205

1.96

3.91

1.3

1.5

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

318

2551

1.27

3.90

3.3

2.4

42.5

38.6

u/l

0.21

267

2209

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

125

2.25

3.89

2.9

2.5

63.2

53.4

umol/l

0.78

104

(3044290) Cell count panel - Cerebral spinal fluid

584

1.56

3.87

1.4

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3044

29754

1.29

3.85

15.1

10.1

27.3

27.5

u/l

0.12

2942

28822

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

159

2.09

3.82

1.2

1.3

12.5

12.3

u/l

0.04

149

(3006462) Nitrate [Presence] in Urine

114

2.29

3.77

4.6

3.4

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

628

1.53

3.77

2.1

1.7

—

(3028271) Lactate [Moles/volume] in Capillary blood

423

1.64

3.76

2.7

1.9

1.5

1.7

mmol/l

0.82

414

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

283

2249

1.28

3.75

4.2

2.5

73.1

68.7

ml/min/173m2

1.02

130

846

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

589

1.54

3.74

6.0

741.3

507.4

iu/ml

0.18

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

566

1.55

3.71

3.7

3.8

59.9

57.4

1.19

566

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

551

1.56

3.69

1.2

1.3

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.70

3.65

1.0

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

3.68

3.63

2.3

—

(1761482) Bacteria [#/volume] in Urine by Culture

578

0.50

3.59

6.1

4.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

314

1.73

3.59

1.1

1.2

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

468

1.59

3.58

1.1

3.0

1175.6

iu/ml

0.55

114

(4024509)

242

1.83

3.52

1.9

1.5

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

217

1682

1.31

3.49

3.3

3.4

4.5

pmol/l

0.02

192

1507

(4211845)

125

2.17

3.47

4.7

3.2

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

2.42

3.47

2.7

2.8

25.5

29.7

umol/l

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

252

1.80

3.41

2.0

1.6

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

2.99

3.41

1.0

1.6

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

202

1.89

3.39

1.6

1.7

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

335

1.68

3.38

1.5

1.7

45.0

58.8

1.42

206

(3020491) Glucose [Moles/volume] in Blood

203

1.88

3.34

3.2

1.6

6.8

mmol/l

0.06

134

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

2.32

3.33

1.0

1.1

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

560

1.51

3.25

1.3

1.2

312.1

268.7

u/ml

0.52

359

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

2.34

3.24

2.0

1.3

13.6

15.5

pmol/l

0.69

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

659

1.47

3.23

2.1

2.4

236.3

129.3

ug/min

0.69

413

(3051611) Lipemic interference index of Serum or Plasma

264

1.75

3.23

3.7

3.2

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

3.58

3.19

2.5

2.3

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

532

1.52

3.15

1.8

1.4

101.6

118.6

u/ml

0.67

101

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

2.96

3.13

1.5

1.1

—

(3051593) INR in Capillary blood by Coagulation assay

2.25

3.12

1.2

12.2

—

(3025315) Body weight

4.51

3.11

6.7

2.8

—

(3002256) Pathology report gross observation

421

3573

1.20

3.09

1.3

—

(3045414) Leukocytes [Presence] in Urine

164

1247

1.33

3.06

1.9

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

2.23

3.05

1.0

1.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

330

1.65

3.04

2.2

2.4

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

10.01

2.98

1.2

233.1

635.4

nmol/l

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

961

0.65

2.96

1.6

1.4

—

(1002224) Polysomnography panel

1302

0.70

2.94

1.0

1.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

141

1055

1.35

2.94

1.4

1.7

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

121

2.07

2.92

2.4

2.7

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

116

842

1.39

2.92

1.9

2.6

0.8

0.9

g/l

0.12

747

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

2.83

2.91

1.0

99.0

98.3

0.04

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

2.83

2.91

1.0

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

585

1.46

2.86

1.7

1.5

—

(44806071)

3.06

2.80

1.0

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

205

0.34

2.78

1.0

1.1

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

168

1301

1.31

2.78

2.7

2.3

—

(21494890) Protein electrophoresis panel - 24 hour Urine

269

1.68

2.78

1.8

2.2

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.27

2.77

1.3

1.2

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

152

1.92

2.75

1.4

1.7

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

104

2.12

2.74

1.2

1.1

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

294

1.64

2.71

1.8

—

(3008536) Aspergillus sp Ab [Presence] in Serum

2.51

2.70

1.7

2.1

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

166

1290

1.30

2.69

3.2

45.9

50.7

u/ml

0.14

161

1246

(3037692) Legionella sp identified in Specimen by Organism specific culture

112

2.06

2.67

1.3

1.6

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

122

911

1.35

2.61

1.8

2.5

3.3

3.0

g/l

2.01

733

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.55

2.61

1.5

1.4

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

245

2007

1.24

2.58

2.9

2.8

314.4

172.3

ng/l

0.83

218

1816

(3018095) Leukocytes [#/volume] in Urine

1020

9381

1.13

2.55

4.6

3.5

79.4

93.5

e6/l

0.32

790

6625

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

396

1.52

2.51

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

209

1.73

2.50

1.4

1.2

—

(3021601) Nitrite [Presence] in Urine by Test strip

1410

13234

1.11

2.44

5.0

4.6

0.0

estimate

0.80

267

2587

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

448

1.48

2.43

1.3

1.4

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1909

18216

1.11

2.43

3.3

3.0

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

2.09

2.42

1.6

2.1

6.4

9.6

mg/l

2.11

(3035880) pH of Pleural fluid

131

1.92

2.40

1.1

1.4

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

727

1.37

2.38

1.3

559.6

524.5

mg/l

0.19

692

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

676

1.39

2.38

1.9

2.0

5.1

4.8

iu/l

0.09

240

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

153

1.84

2.38

1.4

1.7

—

(3009261) Glucose [Presence] in Urine by Test strip

1423

13380

1.11

2.36

3.9

3.4

0.0

estimate

1.34

258

2458

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

378

1.52

2.35

1.6

1.7

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

105

2.01

2.30

1.1

7.1

53.9

61.2

mg/l

0.35

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

111

835

1.34

2.30

1.4

—

(44806118)

324

1.55

2.29

1.7

1.6

—

(44790047)

324

1.55

2.29

1.7

1.6

—

(44790049)

324

1.55

2.29

1.7

1.6

—

(44790048)

324

1.55

2.29

1.7

1.6

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

472

0.57

2.29

1.3

1.2

—

(3044941) Cell count panel - Synovial fluid

439

1.47

2.26

1.7

1.4

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

2.16

2.24

1.2

1.3

36.3

28.8

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

118

900

1.32

2.24

1.8

2.5

9.1

10.3

g/l

2.25

785

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

179

1.74

2.22

1.4

1.6

—

(4038314)

5.56

2.21

1.4

1.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

373

4287

0.85

2.21

1.7

1.5

—

(3024932) HLA-DR beta [Type]

100

2.01

2.20

1.1

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

729

1.35

2.20

1.1

25.3

5.0

u/ml

—

102

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.78

2.20

1.2

1.1

—

(4306422)

476

1.44

2.17

1.1

1.2

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

435

1.46

2.16

1.4

1.5

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

211

1.67

2.16

1.4

1.3

2.3

0.6

u/ml

0.57

(3045716) Anion gap in Serum or Plasma

122

1.89

2.16

4.2

2.6

10.3

9.6

mmol/l

0.20

(3045788) Cell count panel - Pleural fluid

227

1.64

2.14

1.4

1.5

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

692

0.66

2.11

1.5

—

(3024471) HLA-A [Type]

102

1.97

2.10

1.0

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

121

936

1.30

2.09

1.3

1.5

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

693

1.35

2.08

1.9

2.5

0.0

g/l

0.00

650

(3001893) Eosinophils/100 leukocytes in Pleural fluid

2.14

2.08

1.3

1.6

8.6

3.0

0.75

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

5.01

2.07

1.0

—

(3051651) Icteric interference index of Serum or Plasma

161

1.75

2.05

3.7

3.5

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.51

2.01

1.3

1.1

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

459

1.42

2.01

1.2

85.6

45.3

u/l

0.50

395

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

124

970

1.29

1.99

1.7

2.5

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

124

970

1.29

1.99

1.7

2.5

7.7

7.3

g/l

2.28

753

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

742

1.33

1.99

1.9

2.5

0.0

g/l

1.29

697

(4133840)

2.03

1.95

1.1

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

3.75

1.93

1.0

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

2.45

1.93

1.0

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

471

0.61

1.90

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.06

1.90

1.2

1.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

171

1399

1.23

1.90

1.1

1.0

—

(3000034) Microalbumin [Mass/volume] in Urine

259

1.55

1.89

3.0

28.1

32.3

mg/l

0.15

197

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

688

1.33

1.88

1.9

2.5

0.0

g/l

0.00

649

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

123

970

1.28

1.87

1.7

2.5

3.9

3.8

g/l

0.26

719

(3000919) Neutrophils/100 leukocytes in Pleural fluid

2.09

1.86

1.2

1.5

17.7

26.3

0.87

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

475

1.40

1.86

1.1

1.2

4.2

4.9

u/ml

0.22

194

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

469

4191

1.14

1.84

3.7

2.8

2.9

2.2

e6/l

0.87

256

2262

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

4.17

1.82

1.0

1.1

—

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

4.17

1.82

1.0

3.4

0.0

u/ml

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.05

1.80

1.1

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

1.96

1.79

1.7

2.3

63693.8

23120.7

e6/l

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

720

1.31

1.79

1.4

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.76

1.79

1.3

1.2

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

192

1.62

1.77

1.1

1.2

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

446

1.40

1.76

3.5

2.9

—

1580.3

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

102

1.87

1.76

1.3

1.2

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

153

0.39

1.75

1.7

1.4

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

3.34

1.74

1.0

—

(3002523) Influenza virus A Ag [Presence] in Specimen

471

0.63

1.73

1.1

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

726

1.30

1.70

3.3

3.0

1.7

1.5

mg/l

1.46

679

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

605

1.33

1.68

3.4

2.0

0.9

0.8

nmol/l

0.22

508

(3048879) Bone marrow aspiration report

2.03

1.64

1.1

2.3

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

127

1.74

1.64

2.6

1.7

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

549

4993

1.12

1.63

1.6

1.5

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

128

1.72

1.60

1.1

1.2

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.91

1.59

1.2

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

159

1.64

1.58

1.2

1.1

—

(3011648) Oxygen content in Venous blood

215

1.54

1.56

3.8

2.1

10.6

11.2

0.43

215

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

457

1.36

1.56

1.0

1.1

125.7

116.0

2.27

420

(3036489) Thrombin time

132

1077

1.24

1.55

2.2

2.0

20.3

21.4

2.28

107

937

(3043410) Blood group antigens tested for on Red Blood Cells

1.89

1.54

2.3

1.7

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

633

0.71

1.53

1.3

1.4

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

3.34

1.52

1.0

—

(3025549) Creatine [Moles/time] in 24 hour Urine

2.86

1.50

1.8

1.3

—

(3008898) HLA-B27 [Presence]

126

1028

1.23

1.49

1.0

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.90

1.49

1.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

368

1.39

1.47

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

187

1.56

1.45

1.2

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

102

1.77

1.44

1.8

2.5

505.2

777.9

e6/l

0.74

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.73

1.43

1.0

1.2

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

278

0.57

1.43

2.5

2.7

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

2.31

1.43

1.2

—

(3035350) Ketones [Presence] in Urine by Test strip

1383

13213

1.08

1.41

3.8

3.4

0.0

estimate

0.50

257

2500

(21494815) CD4 cells/100 lymphocytes in Specimen

230

1.48

1.38

2.6

2.1

35.7

45.6

1.29

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.94

1.38

1.2

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.87

1.34

1.2

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.50

1.30

1.0

1.2

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

209

1.49

1.30

1.9

2.3

10.5

14.4

1.62

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.29

1.26

1.3

1.2

—

(3003694) ABO and Rh group [Type] in Blood

846

7961

1.08

1.25

1.5

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

123

1.63

1.24

2.1

3.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

566

1.28

1.22

1.6

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.97

1.22

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

116

1.64

1.21

1.2

1.0

—

(3016018) Differential panel - Cerebral spinal fluid

297

1.39

1.20

1.9

1.4

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

103

846

1.22

1.20

1.3

215.3

214.5

miu/ml

0.01

398

(40768793) Breast Pathology biopsy report

559

1.28

1.19

1.4

1.3

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.11

1.18

1.0

1.3

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.11

1.18

1.0

1.3

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.11

1.18

1.0

1.3

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

636

0.75

1.18

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

635

0.75

1.17

1.4

—

(3017704) Immunofixation for Urine

149

1.55

1.17

1.6

1.7

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

2.05

1.15

2.9

1.9

1.2

mmol/l

—

(3020393) Adenovirus Ag [Presence] in Stool

2.50

1.15

1.0

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

2.50

1.15

8.6

5.2

—

(3041354) Potassium [Moles/volume] in Venous blood

283

0.63

1.13

2.4

2.7

4.1

mmol/l

0.44

278

(3035285) Chloride [Moles/volume] in Venous blood

283

0.63

1.13

2.4

2.7

106.4

105.4

mmol/l

0.55

278

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

175

1.49

1.12

1.3

1.5

6.1

7.5

u/l

0.62

151

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.90

1.12

1.2

1.1

—

(3014051) Protein [Presence] in Urine by Test strip

617

0.76

1.10

2.7

2.2

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

647

1.24

1.09

1.2

1.3

4.0

3.8

mmol/l

1.03

611

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.73

1.09

1.1

—

(3025941) Bacteria identified in Stool by Culture

179

1561

1.16

1.08

1.3

1.2

—

(21494814) CD8 cells/100 lymphocytes in Specimen

120

1.59

1.08

2.2

2.0

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2727

27662

0.92

1.08

5.1

4.3

1.3

1.5

mmol/l

39.34

2437

25821

(44813793)

185

1.46

1.08

1.1

1.0

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

101

839

1.21

1.08

2.8

2.5

3.7

3.6

g/l

0.17

793

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.93

1.06

1.0

1.2

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

1.71

1.05

1.2

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

634

0.77

1.04

1.3

1.4

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

482

1.27

1.03

1.1

—

(3006653) Thiamine [Moles/volume] in Blood

163

1.48

1.01

1.2

1.3

147.7

136.0

nmol/l

0.61

163

(3028717) Thiamine [Mass/volume] in Blood

2.00

1.00

1.0

1.3

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.71

0.98

1.1

1.2

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

223

1.39

0.98

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.67

0.97

1.2

1.1

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.96

0.0

1.0

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

276

1.34

0.95

1.1

1.2

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

515

1.25

0.95

2.0

1.7

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.77

0.94

2.9

3.0

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

786

7456

1.07

0.94

1.7

1.4

mmol/l

7.09

693

6292

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

211

1884

1.13

0.93

1.2

145.8

143.8

iu/ml

0.02

719

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

351

3225

1.10

0.92

1.7

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

243

0.66

0.90

2.1

1.5

0.9

1.0

g/l

0.16

243

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.07

0.89

1.0

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.07

0.89

1.3

1.1

—

(3047189) Immunofixation for 24 hour Urine

135

1.48

0.89

1.3

1.7

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

127

0.55

0.88

1.6

1.9

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

277

0.68

0.88

1.3

1.2

—

(40765096) Chromosome analysis panel by Banding

1.61

0.87

1.1

—

(3037556) Urate [Mass/volume] in Serum or Plasma

1.61

0.87

1.4

1.3

—

(3009871) Measles virus Ab [Titer] in Serum

103

1.56

0.87

1.5

1.7

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.86

0.87

5.6

4.6

—

(3047181) Lactate [Moles/volume] in Blood

100

851

1.18

0.87

7.0

6.5

1.2

1.3

mmol/l

0.96

737

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

951

9926

0.94

0.86

4.0

4.6

1.9

2.6

ug/l

2.49

804

8988

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.72

0.86

1.1

1.5

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

107

920

1.17

0.83

2.6

2.1

95.8

91.5

1.37

864

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

463

1.24

0.81

1.6

1.7

—

(3004451) EKG impression Narrative

139

1.44

0.79

1.2

1.3

—

(4268621)

323

1.27

0.76

1.8

2.3

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

166

1.39

0.75

1.0

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

236

1.32

0.74

1.1

32.3

42.2

mg/l

1.21

196

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

228

1.32

0.72

1.1

291.9

284.3

mg/l

0.07

199

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

311

0.74

0.72

1.2

1.4

18.5

4.1

ug/l

0.41

277

(3034426) Prothrombin time (PT)

109

0.55

0.72

1.0

1.2

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.75

0.71

1.3

1.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

151

1.39

0.71

1.2

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

126

1.43

0.70

1.2

1.1

370.0

185.4

iu/ml

0.47

126

(3036603) Volume of Urine

186

1.35

0.70

1.3

1.5

1607.0

2018.8

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

152

1.38

0.69

1.2

1.1

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

233

2137

1.10

0.68

4.1

4.0

1.2

mmol/l

0.69

210

1876

(21491868) Cryoglobulin [Mass/volume] in Serum

121

0.58

0.67

1.0

1.2

—

0.1

g/l

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

153

1.37

0.67

1.3

1.7

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.57

0.65

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.57

0.65

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.57

0.65

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

1.57

0.65

1.0

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

337

0.77

0.63

1.5

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

794

1.15

0.63

1.2

1.1

—

(3033799) Differential panel - Peritoneal fluid

1.50

0.63

1.2

2.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

446

0.81

0.61

1.6

1.7

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.00

0.60

0.0

3.2

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

105

1.43

0.60

1.1

1.2

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

114

1.41

0.58

1.1

3227.2

243.2

ng/l

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

149

1350

1.11

0.58

3.3

2.7

0.6

0.3

e6/l

0.64

143

1314

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

791

1.14

0.58

1.2

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

474

1.18

0.58

3.3

—

(3024263) Appearance of Synovial fluid

149

1.34

0.57

1.5

1.7

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.48

0.57

1.0

1.3

—

(42529406) Shigella sp [Presence] in Stool by Culture

802

1.14

0.57

1.2

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

172

0.70

0.56

6.4

6.6

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.54

0.55

1.1

1.3

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.45

0.55

1.2

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

197

1819

1.09

0.54

1.2

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.45

0.53

1.0

1.3

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

629

1.15

0.52

1.4

36.5

25.8

e6/l

0.16

489

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.50

0.51

1.5

99.3

137.4

ng/l

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

630

1.15

0.51

1.4

2794.9

1407.4

e6/l

0.24

515

(40765089) Chromosome analysis panel - Blood by G-banded

1.39

0.50

1.0

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

422

0.83

0.49

1.2

1.4

0.3

nmol/l

0.60

320

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.56

0.49

1.9

2.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

143

1309

1.10

0.48

1.8

1.9

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

111

1.35

0.46

1.1

1.2

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2805

28251

0.95

0.45

5.4

4.8

2.6

2.8

mmol/l

15.77

2506

26357

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2762

27822

0.96

0.43

4.9

4.4

4.5

4.7

mmol/l

16.47

2477

26089

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.61

0.43

1.8

2.1

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

290

2747

1.06

0.42

4.4

3.2

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

1.52

0.41

1.4

1.8

16.2

7.4

—

(3042951) Complement C1q Ab [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

30.7

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

0.00

0.40

0.0

1.1

—

30.2

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

539

0.87

0.39

1.1

1.2

1.5

u/ml

0.16

217

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.31

0.39

10.4

7.3

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

251

2375

1.06

0.39

2.5

2.2

11.9

13.1

nmol/l

1.14

190

2118

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

114

1047

1.09

0.39

6.1

5.6

2.7

1.7

5.44

107

974

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

0.00

0.39

0.0

2.3

—

(1617658) Protocol used for examination of sentinel lymph nodes

215

0.79

0.39

1.0

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

151

1.26

0.38

1.4

1.2

—

(3044007) Cell count panel - Peritoneal fluid

1.38

0.38

1.1

2.3

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.39

0.38

1.0

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.34

0.38

1.0

1.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.31

0.37

10.1

7.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.35

0.37

1.0

1.1

—

(40761536) Microorganisms panel - Urine sediment

248

2352

1.06

0.37

4.4

3.8

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2657

26760

0.96

0.36

4.5

3.9

1.5

1.3

mmol/l

28.74

2368

24842

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

291

1.17

0.35

1.1

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

0.64

0.35

1.0

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

482

1.12

0.33

1.2

5.1

4.4

u/ml

0.08

153

(3004716) Salmonella sp identified in Stool by Organism specific culture

132

1411

0.93

0.32

1.2

1.4

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

790

0.91

0.32

1.3

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.33

0.32

1.5

9.6

8.7

ug/l

0.24

(3004775) Volume in Urine collected for unspecified duration

220

1.18

0.31

2.1

2.2

569.9

630.0

0.27

150

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

427

1.13

0.31

1.1

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

221

1.18

0.30

1.8

1.9

20.1

18.9

nmol/l

0.25

206

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

185

0.81

0.29

2.6

1.7

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

1.25

0.29

1.1

1.3

—

145.8

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

148

1.22

0.29

1.7

2.0

3.1

u/field

0.43

109

(3010375) cycloSPORINE [Mass/volume] in Blood

139

1.22

0.29

21.9

25.7

136.5

117.2

ug/l

—

114

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

482

0.89

0.29

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

176

1669

1.06

0.29

2.0

1.9

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.32

0.28

1.0

1.2

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

947

0.93

0.27

2.8

3.6

392.5

2576.7

u/ml

1.00

811

(3025130) Human papilloma virus identified in Specimen

363

0.88

0.26

1.9

1.8

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

141

1.21

0.26

2.2

2.4

593.0

1122.5

u/ml

1.49

141

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

132

1.21

0.25

1.4

1.1

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

1.27

0.24

1.2

1.1

105.7

89.8

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

0.71

0.24

1.7

1.5

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

285

0.88

0.23

1.3

1.2

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.28

0.23

1.0

1.1

—

(3023410) Appearance of Cerebral spinal fluid

276

1.12

0.22

1.8

1.5

—

(3052592) Norovirus Ag [Presence] in Stool

1.22

0.22

1.2

1.6

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

1.4

—

(3013762) Body weight Measured

0.00

0.21

0.0

1.4

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.21

0.0

1.0

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.00

0.21

0.0

1.2

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

1.0

—

(3015183) Erythrocyte sedimentation rate

156

0.83

0.21

1.1

1.2

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.21

0.0

1.2

—

2.4

—

(3011325) HIV 1+2 Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

0.21

0.0

1.5

—

1.4

—

(21494434) Karyotype in Bone marrow

239

1.13

0.21

1.2

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

1.16

0.21

1.2

1.1

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

230

0.87

0.21

1.2

1.3

12.8

12.2

mmol/l

0.13

(3016750) Collection duration of Urine

173

1.16

0.21

1.6

2.1

520.3

485.3

min

0.67

128

(4281824)

272

0.88

0.20

1.0

1.2

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

0.20

0.0

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

376

0.90

0.20

1.1

17.3

3.6

u/ml

0.84

138

(3002619) Bacteria identified in Specimen by Culture

1.18

0.19

1.0

1.1

—

(3021589) Normoblasts [#/volume] in Blood

1238

12240

1.02

0.19

12.1

9.3

0.0

e9/l

0.19

1048

10055

(3010726) Horse dander IgE Ab [Units/volume] in Serum

437

0.91

0.19

1.1

6.6

2.0

u/ml

—

106

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

1.22

0.19

1.2

2.2

234.2

168.2

0.76

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

109

1.19

0.18

1.1

1.0

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

589

1.07

0.18

1.3

1.2

13.5

41.9

u/ml

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

126

1205

1.05

0.18

1.4

1.5

—

(3025577) Chromium [Mass/volume] in Blood

166

1.15

0.18

2.1

1.7

2.2

ug/l

0.70

145

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

258

0.89

0.17

1.2

1.4

44.3

172.5

pmol/l

0.62

(3045142) Bone marrow Pathology biopsy report

310

0.90

0.17

1.5

1.4

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

138

1.16

0.17

1.8

2.1

53.5

164.3

ug/min

—

(3035320) C reactive protein [Mass/volume] in Body fluid

184

0.87

0.17

4.2

2.2

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

0.75

0.17

1.0

1.3

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

432

0.93

0.16

1.3

1.2

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

536

1.06

0.15

5.9

3.6

18.6

25.5

mg/l

1.13

330

(3020650) Glucose [Presence] in Urine

0.80

0.14

1.7

1.5

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

202

0.89

0.14

2.2

2.1

0.7

1.8

u/field

1.57

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

316

0.92

0.14

1.0

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

1.19

0.14

1.2

1.3

120.6

88.6

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

0.82

0.13

2.6

2.1

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

0.81

0.13

2.4

2.0

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

132

1.14

0.13

1.1

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

123

1.14

0.12

1.5

1.7

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

123

1.14

0.12

1.5

1.7

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

109

1128

0.97

0.12

1.6

1.7

6.2

3.8

mg/l

1.05

795

(3000963) Hemoglobin [Mass/volume] in Blood

3108

31125

0.98

0.11

34.9

19.5

134.8

137.0

g/l

12.28

3072

30748

(3023430) Cat dander IgE Ab [Units/volume] in Serum

341

0.94

0.10

1.1

7.9

4.6

u/ml

0.29

130

(3010813) Leukocytes [#/volume] in Blood

3108

31120

0.98

0.09

34.8

19.5

8.1

6.7

e9/l

163.67

3065

30330

(3007930) Methemoglobin/Hemoglobin.total in Blood

101

1040

0.97

0.09

6.4

5.7

0.8

0.9

1.66

969

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

959

0.97

0.09

1.9

1.8

43.1

39.4

nmol/l

0.63

926

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

126

1.11

0.09

1.2

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

695

1.04

0.09

1.9

181.9

203.1

pmol/l

0.96

658

(40757373) Influenza virus identified in Isolate

1.07

0.08

2.3

1.8

—

(3026361) Erythrocytes [#/volume] in Blood

3108

31115

0.98

0.08

34.7

19.4

4.4

4.5

e12/l

24.89

3061

30333

(3029075) Extractable nuclear Ab panel - Serum

1.08

0.07

1.0

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

147

1.09

0.07

1.5

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

204

0.93

0.07

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

204

0.93

0.07

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

204

0.93

0.07

1.1

—

(3024731) MCV [Entitic volume]

3108

31111

0.98

0.07

34.5

19.4

92.3

90.9

48.12

3073

30739

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

1.05

0.07

1.4

275.8

154.0

nmol/l

—

(3035941) MCH [Entitic mass]

3108

31110

0.98

0.06

34.5

19.4

30.7

30.3

18.30

3072

30735

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1025

10301

0.99

0.06

4.1

3.5

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

152

0.92

0.06

1.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

180

1.06

0.04

1.2

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

200

0.95

0.03

1.1

1.3

—

(3050129) First trimester maternal screen panel - Serum or Plasma

754

0.98

0.03

1.4

—

(40768795) Lymph node Pathology biopsy report

270

0.96

0.03

1.1

1.2

—

(3036071) Salmonella sp Ab [Titer] in Serum

112

1.07

0.03

1.0

1.1

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

992

0.99

0.02

1.6

1.7

341.6

289.2

mu/l

0.98

901

(3007461) Platelets [#/volume] in Blood

3108

31094

0.99

0.02

34.8

19.5

267.4

251.1

e9/l

31.59

3068

30386

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

207

0.97

0.01

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

207

0.97

0.01

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

207

0.97

0.01

1.1

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

263

1.03

0.01

1.1

1.5

22.4

32.1

0.87

160

(3022621) pH of Urine by Test strip

171

1703

1.00

0.00

3.9

2.7

—

(4027681)

182

0.99

0.00

1.2

—

(3000012) Reticulocyte production index

135

0.96

0.00

1.3

1.6

—

(3018572) Chloride [Moles/volume] in Blood

605

0.99

0.00

7.8

7.6

102.9

105.3

mmol/l

2.12

537

(3023323) Follitropin [Units/volume] in Serum or Plasma

125

1255

1.00

0.00

1.4

1.3

28.6

28.9

iu/l

0.04

1066

(3003888) Timothy IgE Ab [Units/volume] in Serum

476

1.01

0.00

1.0

1.1

9.3

4.6

u/ml

0.46

238

(3039000) Anion gap in Blood

604

0.99

0.00

7.8

7.7

10.8

11.5

mmol/l

0.54

536

(3008401) Mugwort IgE Ab [Units/volume] in Serum

458

1.00

0.00

1.0

1.1

2.5

1.3

u/ml

0.21

189

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

199

1.01

0.00

1.9

2.2

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

136

1.03

0.00

1.0

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

757

1.00

0.00

1.2

1.1

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

0.00

0.0

1.2

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.2

—

1.2

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.0

8.0

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.02

0.00

10.8

7.3

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

0.93

0.00

1.6

1.3

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

400

1.00

0.00

1.1

3.8

3.0

u/ml

0.10

195

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

0.00

0.0

1.2

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3022689) Creatine [Moles/volume] in Urine

0.96

0.00

1.0

1.3

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

0.0

1.2

—

(3022670) pH of Venous cord blood

0.00

0.0

1.2

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

0.0

1.2

—

65.4

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.0

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

0.00

0.0

1.0

—

1289.3

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.0

1.4

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.0

6.4

—

0.3

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

0.98

0.00

1.0

1.1

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3004282) Tumor necrosis factor.alpha [Mass/volume] in Serum or Plasma

0.00

0.0

3.0

—

52.2

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: F5_TOBAC – Mental and behavioural disorders due to tobacco

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Mental and behavioural disorders due to tobacco

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Mental and behavioural disorders due to tobacco (F5_TOBAC)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints